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THE TREATMENT OR SYPHILIS BY ARYLARSONATES. 
INTRODUCTION. 
As a result of the recent rapid advances made in 
almost every department of medical science and espec- 
ially in pharmacology and experimental therapeutics, 
the gradual abandonment of empirical for rational 
therapy, the expression of opinions, some of which 
were almost revolutionary in character, the introduc- 
tion of the ultra- microscope, the improved methods 
employed in the culture and staining of micro- organ- 
isms, the improved technique of serum diagnosis and 
serum treatment, the introduction of the opsonic the- 
ory, and the elaboration of both synthetic and bio- 
chemistry, it was but natural that scientific men, 
both at home and abroad, should again have turned 
their attention towards the elucidation of the real 
aetiology of Syphilis, a disease said to be almost as 
old as the human race itself. By common consent, 
based almost wholly on clinical grounds, this disease 
had long been included among the granulomata which 
are definitely known to be of microbial origin, and 
treated on purely empirical grounds. 
On referring to the writings of Hippocrates and 
Galen, we find no reference whatever made to any such 
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malady. Passing to the dark and middle ages when 
superstition was rife, we find many and diverse - and 
even, as was to be expected, superstitious - views 
expressed about this malady which by then had fallen 
as a plague on Continental Europe. With the dawn of 
bacteriology in the nineteenth century and its rapid 
advances in the twentieth, scientists began to sus- 
pect, from its clinical pictures, and by a comparison 
with other diseases, that Syphilis was of microbial 
origin and many observers discovered micro- organisms 
which were alleged to be the causative factors. 
Their views, however, almost without exception, were 
of short duration and soon consigned to the limbo of 
things forgotten. 
In 1884 Lustgarten(l) discovered a bacillus - 
closely allied and by some said to be identical with 
the smegma bacillus - which he alleged to be the cause 
of Syphilis. About ten years later, Van Niessen(2) 
discovered a diphtheroid bacillus which he alleged 
was the cause of this malady. These two discoveries 
by these scientists met with some degree of support. 
In 1902, however, Schüller(3) discovered a protozoon 
which along with the bacilli of Lustgarten and Van 
Niessen continued to hold the field, until 1905 when 
Schaudin(4) and Hoffmann(4) in somewhat guarded lan- 
guage, announced to the scientific world their epoch- 
3. 
making discovery, that the disease was caused by a 
spirochaeta called by them the "SpirochELeta Pallida" 
on account of its staining properties. 
It is now almost generally accepted that the 
real cause of Syphilis is the protozoon of Schaudin 
and Hoffmann and this has since been confirmed by 
other observers as Niesser,Flexner(5), Uhle, Roux, 
Iackinney 
(6) 
and Metchnikoff. This then brings us on 
to the consideration of protozoal diseases. 
Besides the bare mention that protozoa are uni- 
cellular organisms and belong to an ill- defined group 
of the animal kingdom of which the amoeba represents 
the simplest type, and the fact that they are classi- 
fied as follows: - 
1. Sarcodina with pseudopodia, 
2. Mastigophora with flagella, 
Protozoa 
3.. Infusoria with Cilia, 
4. Sporozoa with no motile organs, 
I do not propose, and it is not within the scope of 
this thesis, to enter into their life history and 
sub- classification, etc. All this information can 
be gathered from special text books on Zoology, 
Bacteriology and various medical publications. After 
the brilliant discovery of the late Professor Koch 
that African Sleeping Sickness - a protozoal disease 
- was caused by a trypanosoma, and his authority 
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that Atoxyl (an organic preparation of arsenic and 
aniline) was a specific for that malady, protozoal dis- 
eases assumed great importance from their therapeutic- 
al aspect. Bacterial and protozoal diseases differ 
in these essentials: - 
(a) The former (e.g. tuberculosis) are caused by 
infection from the vegetable, while the lat- 
ter (e.g. malaria, syphilis) are caused from 
the animal world. 
(b) The former nearly always undergo the whole 
phase of their evolution or life history in 
one host while the latter, almost without 
any exception, require more than one host. 
Many are the points of similarity and dissimilar- 
ity between protozoal and bacterial diseases. 
In some bacterial diseases where the causative 
micro -organisms can be cultivated in vitro, the corres- 
ponding rational therapy resolves itself into the ad- 
ministration or introduction of anti-bodies in various 
definite amounts into the body of the host with a view 
to destroying or otherwise preventing the action of 
the germs themselves or the baneful bodies eliminated 
or produced during the growth and evolution of the 
bacteria. 
In protozoal diseases, where the causative organ- 
isms pass their life cycle through several hosts, it 
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is difficult, if not wholly impossible, to cultivate 
the micro -organisms in vitro and hence the difficulty 
of preparing antibodies to meutralize the morbific 
substances produced during that period of their life 
cycle in man, the host in which, as physicians, we 
are interested. 
It would suit my purpose to briefly consider 
specifics which are drugs, bodies or remedies which 
have specific or infallible actions or power in parti- 
cular diseases. As examples of them, I may mention 
mercury in Syphilis, and quinine in Malaria. 
When mercury is administered in Syphilis, it is 
said to gain entrance to the special cells of the 
syphilitic lesions and cause a separation of their 
nuclei. The cells then undergo fatty degeneration 
and are absorbed. 
In Malaria, if quinine be administered in ade- 
quate doses and in time to be absorbed and exert its 
specific therapeutic action just before the Zygo- 
blasts of the Malarial plasmodium are floating free 
in the blood plasma (i.e. after they have been ex- 
truded from the erythrocytes) it causes their rapid 
destruction and elimination. 
Some specifics are "rational ", others "empirical ". 
Many and diverse opinions have been expressed as to 
the specificity of the arylarsonates in Protozoal 
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diseases. In some forms of protozoal diseases, e.g. 
sleeping sickness (as mentioned above), Atoxyl, an 
arylarsonate, brings about, according to some author- 
ities, a permanent cure, e.,. when animals with try- 
panosomes in the blood are injected with Atoxyl 
(mono- sodium -- para -amido -- phenyl-- arsonate) the trypano- 
somes disappear, although the blood is still infec- 
tious. If both Atoxyl and Mercury are injected, the 
trypanosomes are entirely destroyed. If the same 
experiments are carried out in patients suffering 
from trypanosomiasis, Atoxyl alone is found sufficient 
to destroy the trypanosomes. 
Applying the argument that trypanosomes and 
spirochaetae are morphologically related to each other, 
it is but natural that remedies found beneficial in 
trypanosomiasis should be tried in cases of spiro- 
chaetal infection. 
In Syphilis (a chronic spirochaetosis) it is 
found by experiment that Atoxyl treatment causes the 
rapid disappearance of chancres, gummata and skin 
eruptions when injected in their immediate vicinity. 
Certain other syphilitic lesions (e.g. visceral syph- 
ilis and meta- syphilitic affections), however, are 
said to remain unchanged. Arsenic (and Atoxyl is an 
arsenical preparation) therefore in suitable forms is 
of considerable therapeutic value and is useful where 
mercury and iodides are making little or rio progress 
or, for various reasons, are badly tolerated. Be- 
sides atoxyl, other arsenical preparations, e.g. 
Orsudan, Soamin, Arsacetin, Arseno-phenyl-glycin, 
Atoxylate of Mercury, Dioxy- diamino- araeno-- benzol, 
etc. have been experimentally used for the same pur- 
pose. 
I may hero quote some of the conclusions of Pro- 
fessor Halloneau in the use of Atoxyl and in the 
chapter on the history of the Arylarsonate treatment, 
I shall deal very fully with the various views ex- 
pressed by various people on the subject. According 
to him, then, "It would very probably be possible to 
"cure Syphilis by injections of Atoxyl if it were 
"possible to repeat thorn for a long enough period at 
"sufficient doses. Unfortunately this is not pos- 
"sible and the injections have to be stopped after a 
"varying number have been given owing to symptoms 
"indicating intolerance." 
Among the diseases now definitely known to be 
protozoal are the following:- Sleeping Sickness, 
Dourine, Nagana, all due to trypanosomes; Malaria 
to the Plasmodium malariae, a protozoon or haemato- 
zoon; Kala -azar to the Leishmania Donovani; Syph- 
ilis to the Treponema Pallidum; Yaws to the Treponema 
Pertenue; Relapsing Fever to the Spirillum Obermeieri. 
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Besides these the reported good results of arsenical 
treatment in Pellagra, Pernicious Anaemia and certain 
skin diseases raises the question of the protozoal 
origin of these. 
Passing now to the therapeutic aspects of morbid 
conditions in which we, as physicians, are concerned, 
it immediately occurs to us that there must be some 
essential difference between the action of trypano- 
cidal drugs "in vitro" and "in corpore". Bearing in 
mind what has already been said, that it is difficult, 
if not wholly impossible, to cultivate protozoa in 
artificial media "in vitro" on account of their pass- 
ing their life history through more than one host, we 
find that even in cases where their life history has 
been fully worked out, e.g. the plasmodium malarîae, 
we have got no nearer to any rational mode of treat- 
ment since vaccine therapy is only possible in some 
cases where the organisms can be cultivated in vitro. 
There is thus little cause for wonder that the 
remedies tried in protozoal diseases have been legion 
and are almost wholly empirical. 
In the administration of a drug to combat a 
bacterial infection, we must consider 
(a) The effect of the remedy upon the host and 
(b) Its effect on the invading or infective 
micro -organisms. 
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We must then exhibit the drug in quantities that 
will be destructive to the micro -organisms or their 
products or both, and at the same time innoxious to 
the host, e.g. when Quinine is exhibited in Malaria - 
a microbial or protozal disease -- it causes in modor- 
ate doses, administered at the proper time, a total 
disappearance of the plasmodium from the Erythrocytes. 
If given in large doses, it also acts on the host, 
causing in man the following: - 
(a) A decrease or even cessation in the amoe- 
bold movements of the leucocytes. 
(b) A specific baneful action on some of the 
organs of sense (e.g. that of hearing) and on some 
portions of the nervous system. 
(c) Certain cutaneous eruptions. 
If it were possible to cultivate protozoa in 
vitro we would then establish a rational therapeutic 
basis and by repeated experiments on animals, and 
even on man, we would no doubt be able to determine 
what dose of the specific to exhibit and I have little 
doubt that it would assume the form of some antibody 
or vaccine: 
The scope of my thesis is the following: - 
(1) To give an outline of the history of the 
subject and its position at the present time. 
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(2) To compare the results of different Arylar- 
sonates, and show whether they hold out promise of be- 
coming established therapeutic agents. 
(3) To give the results of trial in a series of 
cases of the various Arylarsonates paying special at- 
tention to the action of the preparation in bringing 
about a permanent cure as proved by the absence of 
the Wassermann 
(7) 
reaction after treatment. 
I may mention that the apparatus I use for test- 
ing the Wassermann reaction in cases of Syphilis treat- 
ed by me and in other diseases where I suspected a 
syphilitic taint, is the Syphilis Diagnosticum outfit. 
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HISTORICAL OUTLINE. 
Recent research by Ehrlich and others has con- 
cerned itself with the investigation of various chem- 
ical compounds which by their action on the parasites 
or toxines within the body either cause destruction 
or neutralization of the rnorbifis agent and so cure 
the disease. In this section of my thesis I propose 
to give an account in chronological order of the in- 
troduction of the most important arylarsonates which 
have been used in the treatment of Syphilis which in 
the light of modern medical research has been already 
justly described as a chronic spirochaetosis or 
spiLillosis. In the chapter on the Chemistry of the 
Arylarsonates, I shall define this term. The arylar- 
sonates which I shall bring before your notice are 
Atoxyl, Soamin, Arsacetin, Arsenophenyl- glvcin, Mer- 
cury Atoxylate and the newest and most important pre- 
paration of all, viz: Dioxy-diamino-arseno-benzol,also 
known as Ehrlich -Hata preparation No.606.. (Salvarsan). 
Mercury in various forms has for a long time 
been used empirically in the treatment of Syphilis 
and the medical profession has long since recognised 
that there are instances, some of which can be ex- 
plained only on the hypothesis of an idiosyncrasy, 
and others where definite renal and hepatic lesions 
exist, that mercury, even aided by other drugs like 
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the iodides, had little, if any, action on the disease 
or could not be administered with impunity. In some 
cases lesions either known to be syphilitic or to have 
a close relation to this disease (e.g. para- or meta - 
syphilitic lesions) were found to be refractory to the 
use of mercury in any known form -- perhaps owing to 
the treponema in its life history in mari assuming a 
form unaffected by mercuriale. It is not surprising 
then that medical men began to try other remedies in 
order to discover, if possible, some substitute for 
mercury. It was observed that Arsenium both in its 
physical properties and its chemical compounds bore 
strong resemblance to Mercury. It was also discovered 
by experimental pharmacology that it (arsenic) could 
be exhibited in very much larger doses when in an 
organic form than was formerly possible in the inor- 
ganic compounds that were used. 
The first arylarsonate which I shall bring to 
your notice is Sodium -amino -phenylarsonate also called 
ATOXYL (a registered trade name) which was first pre- 
pared over fifty years ago by the French Chemist 
Bechamp and which was introduced into medicine about 
ten or twelve years ago. 
In laboratory experiments, Thomas & Breinll, 
found that it had a marked trypanocidal action and 
naturally suggested that it should be used in Sleeping 
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Sickness, a disease then known to be of protozoal 
aetiology from the researches of Castellani, Bruce, 
Nabarro and Low. The Liverpool School of Tropical 
Medicine then formally introduced this drug in the 
treatment of Sleeping Sickness and its subsequent use 
by Koch on a large scale in Sleeping Sickness in 
Uganda proved its undoubted therapeutic efficacy. 
In 1905 came Schaudin & Hoffmann's(2) epoch- making 
discovery of the protozoal nature of Syphilis and the 
subsequent classification from morphological and other 
grounds of the protozoon as a Treponema. Proceeding, 
then, on rational lines, it was but natural that a 
remedy which had proved its efficiency in one proto- 
zoal disease should be given a trial in another, viz. 
Syphilis. The results were marvellous and workers 
on the Continent vied with one another in publishing 
the results of their experiments. As far as I am 
aware, Atoxyl was first used in the treatment of 
Syphilis at the Institut Pasteur, and the resulta ob- 
tained there when first published were received with 
much scepticism. I cannot do better than to summar- 
ise the statements made and views expressed by eminent 
authorities when the publications of the Atoxyl treat- 
ment were first received. P. Meissner(3)said that 
so favourable were the reports received from France 
of the use of Atoxyl in the treatment of Syphilis 
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that some ascribed them to the natural enthusiasm for 
exaggeration existing among Frenchmen. The reports 
were first received with scepticism, but when differ- 
ent investigators in other lands reported similar re- 
sults we could not help but believe them and recog- 
nise the fact that a new era in the treatment of 
Syphilis had dawned. 
In "Arsenic bei der Syphilis- Behandlung ", the 
epoch -making work of. Paul Salmon(4) he said that he 
had treated a certain number of syphilitic patient 
with arsenic alone and had obtained most encouraging 
results, that Atoxyl had a favourable influence for 
certain trypanosomaland spirillar diseases, and that 
from that time arsenic could be reckoned a specific 
in Syphilis. He found the remedial action evident 
three days after a single injection of 5 gramme 
(7 grains) of Atoxyl and that in less than two weeks 
the curative process was complete with a rapidity at 
least equal to that of mercury, and that the general 
and local atoxicity of Atoxyl gave it great advantages 
over Mercury and Iodide of Potassium. He observed 
in none of his cases any intolerance to three grammes 
of Atoxyl in one week. The same author in another 
article(5)came to the conclusion that Atoxyl could 
be distinguished by:- 
(a) The certainty of its results, 
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(b) The rapidity of its action, 
(c) The rapid healing of the different forms of 
the disease. 
Other investigators in other countries reported 
that it was useless, and abandoned it until the appear- 
ance of Salmon's epoch -making work (already mentioned 
above) rekindled their enthusiasm. 
At a meeting of the "Berliner Medizinischen 
Gesellschaft" on February 13th, 1907, and in No.16 of 
the Berliner Klinischen Wochenschrift, 22nd April 1907, 
Professor Lassar's attitude was to the effect that 
Atoxyl was useless against Syphilis. 
Shortly after (May 1907) in his lecture on 
"Atoxyl in Syphilis" before the Berlin Medical Society, 
he, as a result of the researches of Salmon, Hollopeau 
and Metchnikoff, began to alter his opinions on the 
use of this drug in Syphilis. He said that he had 
observed no ill effects, that the quantity of the drug 
had nothing to do with its effects which were due to 
the fate encountered by the drug in the organism-de- 
pending probably on the greater or lesser alkalinitl 
of the blood. He found that a 10% sterilised solu- 
tion thrice weekly was enough to produce a retrogres- 
sion of the symptoms whether it was a recent or chron- 
ic case, and that when the drug was injected in the 
gluteal regions, it had the same effect on primary 
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sores as corrosive sublimate injections. He observed 
an abatement of all the symptoms,(a retrogressive 
metamorphosis) that Atoxyl behaved like mercury, and 
he hailed the drug as another specific. He hoped 
that the medical profession would recognise that 
Atoxyl was of paramount importance and would investi- 
gate, as he then was doing, its action on diseases of 
the central nervous system that had until that time 
resisted Mercury and the Iodides. At the same meet- 
ing of the Berlin Medical Society, and in the paper 
" Untersuchungen über dia Wirking des Atoxyls auf die 
Syphilis" further reports on use of were 
(6) 
recorded by P. Uhlenhuth, E. Hoffmann, and K. Roscher. 
Two eminent syphililogists working under the di- 
rection of Professor Dr Lesser reported that the drug 
was particularly useful in Syphilis ulcerosa praecox 
(malignant Syphilis) and Hoffmann endorses this view. 
In his work "Sur le traitement de la Syphilis 
par l'anila.rsinate de soude suivant la procédé de M. 
Paul Salmon ". Professor Hallopeau(7)confirmed 
the opinions of the former author, and noted cases 
of intolerance of the drug. He advised U.S not to 
abandon the drug on account of these incidents, that 
toxic effects were observed when other drugs as Opium, 
Chloroform, Mercury, Digitalis and Cocaine were first 
used, that these latter drugs were not set aside 
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because accidents sometimes occurred with them, that 
it had a favourable influence on Syphilis and that the 
symptoms of intolerance were of secondary importance. 
On June 10th, 1907, Professor E. Lesser in the 
course of an address to the "Verein für innere Medizin" 
on "The treatment of Syphilis in the light of the lat- 
est results of Research" said that in every case the 
symptoms rapidly disappeared, the results obtained 
were excellent, malignant syphilitic ulceration healed 
rapidly, that especially in galloping Syphilis it ap- 
peared to be equal to calomel injections in its re- 
sults, and that it was the best method of treatment 
hitherto known. 
In the "Naturwissenschaftlich -medizinischen 
Geselschaft zu Jena" at a meeting held on June 20th, 
1907, Spiethoff(8)gave a "Report on the present posi- 
tion of Syphilis investigation" in which he said that 
with intra- muscular injections all lesions in the 
primary and secondary stages of the disease and even 
gummata rapidly disappeared. 
Dr Felix Moses(9)in a papar "Der heutige Stand 
der Atoxyl- behandlung der Syphilis" recommended its 
use where treatment was necessary and Mercury could 
not be used. 
(10) 
Dr A. Darier in an interesting paper "De 1' 
atoxyl dans la Syphilis oculaire" said that syphilitic 
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iritis improved rapidly under its use and held out 
promises of being completely cured. Numerous others 
(11) (12) 
as Rouviere , Krauss & Scherber also report 
favourably on the Atoxyl treatment. 
(13) 
The investigations of Neisser have an extensive 
bearing upon the whole subject. He said that the re- 
ports which were published showed the healing of ex- 
isting symptoms, but nothing was expressed as to wheth- 
er a complete destruction of the virus present in 
the body took place in order to exclude any recurrence 
of the symptoms. He had made experiments on animals 
and was able to affirm that if the Atoxyl treatment 
was energetically prosecuted (large single doses be- 
ing most effective) it had a most powerful influence 
On the disease, that the experiments were not aimed 
at ameliorating the symptoms but to ascertain whether 
the virus was killed, that while inoculation from the 
organs (spleen, bone -marrow, etc.) of animals in which 
the disease was left to itself or treated with var- 
ious other drugs almost invariably led to positive 
infection, inocula£ ion after Atoxyl treatment almost 
invariably gave negative results, and that he had not 
yet ascertained whether a complete sterilisation of 
the animals was attained or only such a degree of 
annihilation that the remaining traces escaped trans- 
mission by the organ inoculation. 
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All I have quoted, then, prove beyond doubt that 
Atoxyl exercises an actual specific action on Syphilis. 
Besides its use as a curative agent, it possesses 
properties which, when exhibited in proper doses and 
at definite ascertained periods, are said to prevent 
the appearance of syphilitic symptoms after inocula- 
tion. 
Hoffmann, Uhlenhuth and others made experiments 
on rabbits and concluded that its effects were not 
only healing, but also preventitive, and that the 
utilisation of these results would appear to be indi- 
cated for human syphilitic pathology. 
In September 1907, Metchnikoff related to the 
audience at the International Congress of Hygiene at 
Berlin the results of experiments he had conducted on 
anthropoid apes with Atoxyl as a prophylaxie in Syph- 
ilis. 
He recorded two sets of experiments controlled 
by other monkeys to which no Atoxyl was administered. 
In the first set of experiments he exhibited 
Atoxyl subcutaneously at intervals of a few days after 
inoculation with the specific virus, and no symptoms 
appeared. 
In the second set of experiments, he injected one 
dose a long time - about fifteen days - after inocula- 
tion and no syphilitic symptoms also appeared. As 
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the result of these experiments, he concluded that 
besides a healing action on already existing syphil- 
itic symptoms, Atoxyl also possessed a prophylactic 
action. 
(14) 
Wassermann used it in meta- or para -syphilitic 
lesions, and, as was to be expected, it had no effect 
upon already formed organic lesions of the central 
nervous system. Some authorities, however, consider 
that it holds out good prospects as a prophylaxis 
even in these lesions. As is customary after the 
appearance of a new remedy and the zeal of early ex- 
perirnentists, certain alarming symptoms did 
They were mostly of the nature of arsenical poisoning 
with all its usual signs. These toxic symptoms seemed 
to affect principally the eyes and many cases of blind - 
ness occurred. 
(15) 
Von Graefe's , in his memoir, treats of the 
action of Atoxyl on the visual apparatus at great 
length and gives an account of thirty -seven cases in- 
cluding most of those given in the tables in Bulletin 
No.8, p.308, and some others. Igersheirner and Pader- 
stein do not differ very much in their descriptions of 
the onset and course of Atoxyl amblyopia. They re- 
gard the prognosis as unfavourable and therapy_as 
owerless. Igersheimer experimented on different 
animals to which he had given Atoxyl in various ways, 
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and out sections of the nerve apparatus of the eye. 
As the result of these experiments, he came to the 
conclusion that Atoxyl had a selective action on the 
nerve cells of the organ of vision without setting up 
reactive processes in the neighbourhood of the degen- 
erative focus,that the point of attack of the poison 
may be central, peripheral, or, in the course of the 
optic nerve, that often the substance seemed to be 
fixed ( verankert) at several points at once and to 
evoke simultaneous morbid processes. He said that 
in arsenical poisoning, affections of the optic nerve 
were rare while the prognosis was good, that rarer 
still were the affections of vision attributable to 
aniline the prognosis of which was again favourable, 
and that one was compelled to think that the specific 
action of Atoxyl was independent of its arsenic or 
aniline components. He compared in various animals 
the symptoms and post -mortem lesions of poisoning by 
aniline and arsenic on the one hand and Atoxyl on the 
other, pointed out that renal haemorrhages almost al- 
ways occurred in Atoxyl poisoning of the dog, but very 
rarely after poisoning by arsenic, that in the bulb 
of the dog and cat after several days' treatment with 
Atoxyl arsenic was found, but after the administration 
of the equivalent quantity of sodium arsenate none 
was found. The following is a summary of some of 
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Igersheimer's conclusions. 
(1) Atoxyl amblyopia in man in most cases occurs 
under the form of a simple progressive optic atrophy 
in which pallor of the papilla may occur very early 
or very late. Quite exceptionally (Fehr's cases) 
the amblyopia is stationary and in the form of a re- 
trobulbar neuritis. 
(2) Extreme changes purely of a parenchymatous 
nature are found in the optic nerve fibres near the 
chiasma in post -mortem examinations in men. 
(3) There was nerve degeneration in the eyes of 
rabbits when small and moderate Quantities of Atoxyl 
were introduced under the conjunctiva or into the 
vitreous humour. 
(4) There occurred degenerative processes in the 
inner layers of the retina and in the optic nerve in 
dogs and cats when Atoxyl was administered subcutane- 
ously. 
(5) Cats became very nervous after Atoxyl, and 
after death marked changes were seen in the cells of 
the brain and spinal cord with special localization 
in the optic thalamus. 
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(6) In man atoxyl amblyopia had a different 
clinical course from that caused by arsenic and anil- 
ine. 
(7) Chemical examination showed that very strong. 
affinity exists in the bulb for the atoxyl molecule 
but not for inorganic arsenic. 
(8) These changes are independent of affections 
of the internal organs. 
(16) 
Mr Ernest Clark also has had several cases of 
optic atrophy to record after the use of atoxyl. 
It was early recognised that the exact chemical 
composition of Atoxyl (according to the source of its 
manufacture) was subject to great variation; and that 
different preparations of the same drug had different 
therapeutic effects. The amount of arsenic in it 
was found to be inconstant depending on its mode of 
preparation and the amount of water of crystallisa- 
tion it contained. Some of the early preparation 
(especially the German ones) were very toxic and gave 
rise to severe cases of poisoning. The exact chem- 
ical nature of the drug then became the subject of in- 
vestigation and an extensive series of researches on 
the arylarsonates were commenced by Messrs Burroughs 
Wellcome & Co. in 1907. The result of these experi- 
ments was the introduction into therapeutics of 
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Orsudan and Soamin which differ little (apart from 
chemical composition, water of crystallisation, solu- 
bility, and amount of arsenic present) from each other. 
SOAMIN, then, is the arylarsonate I propose to deal 
with next. It is a registered trade name and a pure 
and stable form of Sodium -para- amino -phenylarsonate. 
After numerous experiments by competent observers, 
this drug has not been found wanting and the results 
obtained with it have been very striking. The first 
published report of its use occurred in the Journal 
of the Royal Army Medical Corps of April 1908 and re- 
ferred to thirty cases, some of which were of great 
severity. To obtain an accurate idea of its thera- 
peutic value it was exhibited only in those cases 
where the diagnosis of Syphilis was established (by 
every available means) beyond a doubt. The writer 
of the article referred especially to the absence of 
any symptoms of intolerance or toxicity after its use 
and said that in no single case did the patient com- 
plain of any symptoms which could be attributed to the 
drug. Its beneficial action seemed to be most marked 
in those cases where there was ulceration of the mu- 
cosa of the mouth, tongue or throat. In five of the 
thirty cases recorded here a very marked change in the 
condition was noticed even after the second injection, 
by which time the ulcers had assumed a much cleaner 
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condition. In one week dirty foul ulcers healed up. 
Its action was well marked in one severe case in this 
category. From a study of these thirty cases, we 
find that Soamin causes a complete disappearance of 
the symptoms of the disease. With reference to its 
power to effect a permanent cure, the author said it 
was yet too early to know how many injections were 
necessary to stamp out the disease, that a consider- 
able amount of work remained yet to be done in connec- 
tion with the treatment, that in Soamin we had a very 
valuable agent in the treatment of Syphilis, that its 
action on the lesions of early Syphilis appeared to be 
equal to, if not better than that of mercury, that it 
had many advantages over Mercury without any disadvan- 
tages, that it was very easily injected and dissolved 
readily in hot distilled water, its injection was ab- 
solutely painless, there was not yet a single com- 
plaint of pain or tenderness after injection nor the 
least suspicion of induration or thickening, its in- 
jection was not followed by salivation or spongy gums 
(so frequent a complication with Mercury), and that 
in India and other tropical countries when the pat- 
ients, already debilitated by disease or climatic con- 
ditions, were unable to take Mercury in any form, it 
was of special value because it had a tonic and al- 
terative action. 




In the British Medical Journal of August 15th, 
1908, pp.391 -4, Colonel F. T. Lambkin, R.A.M.C. gave 
a record of thirty cases treated by him between March 
1st, 1908, and July 1st, 1908. In these cases he 
used Soamin alone and said that during that time he 
had not seen a single sign of any toxic effect of the 
drug although the dose (injected intramuscularly) had 
been considerably increased. He drew attention to 
its beneficial effects in secondary lues and noticed 
that since its introduction, ulcerated throats became 
very rare. In all these cases the drug had a good 
effect on the general health and all the patients 
gained weight. In the Lancet of December 5th, 1908, 
he gave a further detailed account of thirty-four 
cases of Syphilis which were treated by him at the 
Military Hospital at Rochester Row. Again, in these 
cases, its value is fully borne out and its relative 
non -toxicity as compared with Atoxyl, arsenic acid 
and inorganic arsenical salts well marked. 
In the Medical Press and Circular (November 4th, 
1908, pp.494-b) G. Pugin Meldon reported favourably 
on its uses and said that he believed that a few 
weeks of Soamin treatment gave one a better chance 
of warding off the disease than a short mercurial 
course. In the same paper of November 14th, 1908, 
Dr Robert Robertson stated that he obtained very 
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pod results with it in a case of Syphilis of long 
duration in a married woman. In the Lancet, Decem- 
ber 26th, 1908, are recorded very rapid healing of 
malignant tertiary ulcers after four injections of it. 
In the British Medical Journal of December 12th, 1908, 
p.1788, we find recorded the rapid healing of intrac- 
tibie specific ulcers and in this same paper of August 
28th, 1909, we read of eases demonstrating its value 
in long standing cases of tertiary Syphilis where 
Mercury had no appreciable effect. E. U. Bartholo- 
( ) ( 
18 (19) 
mew(17), Benjamin Moore , and Lambkin all con- 
firm these reports of the beneficial influence of 
Soamin. 
The toxic effect (denied by some) on the eye has 
been very rarely observed and perhaps this is due to 
the fact that it has not been as extensively used as 
Atoxyl. 
I now pass to ARSACETIN, an acetylised form of 
arsenilate of Sodium, introduoed by Ehrlich, and the 
production of which is one of the triumphs of syn- 
thetic chemistry. Those who have used it say that 
it is remarkable for its low toxicity, good keeping 
qualities and the sterilability of its solutions. 
Ehrlich(20), Browning (21) and Salmon(22) have 
used it extensively and found that it is for many 
species of animals three times less toxic and in the 
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maximum four or five times lees than the arsenilate 
(Atoxyl). Neisser and Salmon found that in monkeys 
- which of all animals used in the experiments show 
the greatest affinity to man - that no bad results 
followed its use, and that an ape of two kilos (body 
weight) was able to tolerate,and be in good health, 
as much as fourteen graine of it in four doses within 
ten days. Experiments made by Ehrlich and Browning 
with animals (mice) infected with trypanosomiasis have 
proved that even the severest case which otherwise 
would result in death within a few hours can be treat- 
ed successfully with arsacetin, whereas Atoxyl, even 
in very slight infection had hardly any effect. Ex- 
periments on various other species of infected animals 
(trypanosomiasis as well as other protozoal diseases) 
have given excellent results throughout so that the 
introduction of this product into therapeutics as a 
method of treatment for the human being seemed ration- 
al and fully justified, if any importance at all can 
be attached to experiments on animals. Professor A. 
Neisser(23)gave the results of the employment of 
Arsacetin (Ehrlich) in the treatment of Syphilis to 
the effect that by means of experimental research we 
had reliable knowledge of the activity of Mercury and 
also that besides Mercury other specific remedies ex- 
isted, that he would report on a new arsenical pre- 
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paration (arsacetin), that the experiments on animals 
carried out by Uhlenhuth, Metchnikoff and his staff 
proved with absolute certainty that there were arseni- 
cal preparations which were able to destroy completely 
the syphilitic virus in the body without harm to the 
animal, that besides the older Atoxyl, we had a new 
preparation arsacetin prepared by Ehrlich and exten- 
sively tried by himself during his stay at Batavia, 
that the preparation was introduced to meet the desire 
for a less toxic but equally active preparation 
as Atoxyl, that compared with Atoxyl, its solutions 
were very stable at high temperatures, and it could 
even be heated in au.tocloves to 13000. without suffer- 
ing decomposition and liberation of arsenic, that the 
preparation was certainly less toxic than Atoxyl, its 
remedial action on Syphilis was at least equal to that 
of Atoxyl, its solution could be stored for long per- 
iods without undergoing decomposition, he could re- 
commend it as a very useful preparation, that to judge 
the efficacy of a syphilitic remedy from its sympto- 
matic relieving action was wholly false if the proof 
had already been furnished in indisputable fashion-- - 
by experiments on animals- -fthat the drug possessed a 
reliable curative, virus -destroying action, that they 
had not observed a single case of optic atrophy or of 
similar damage to the nervous system, that no renal 
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disturbances had been observed, passing pain in the 
stomach and intestines sometimes occurred, and that 
although men with healthy organs tolerated Arsacetin 
well, it appeared that already diseases or enfeebled 
organs were more susceptible to the toxic action. 
(24) 
Colonel Lambkin confirmed Neisser's results 
(25) 
and in his paper "The Arylarsonate treatment of 
Syphilis; its possible future effects on the services" 
he spoke very highly of the results he had obtained 
with it. He said that at present our knowledge of 
the power of these salts of arsenic over Syphilis was 
in a very elementary stage, but he looked forward to 
future experience and improved technique leading us 
to that goal in the treatment of Syphilis which had 
already been attained with dourine. The same auth- 
or(26)said that he had tried the drug in a large 
number of cases and had found it beneficial in prim- 
ary lesions as well as in cutaneous Syphilides and 
those of the mucous membranes. It is important to 
(27) 
note that Professor Neisser said that it would be 
a mistake - except in cases where Mercury was not 
tolerated at all, or its action failed (Mercury -re- 
sistant Spirochaetes ?) - to abandon Mercury with its 
established action, for Acetatoxyl (= Arsacetin) the 
therapeutic value of which, in human Syphilis, was 
not yet sufficiently known, and that he would for the 
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present combine both drugs, either employing them 
simultaneously or successively. 
The next Arylarsonate which I pass on to discuss 
is ARSENO- PHENYL -GLYCIN (in vacuo) also called Spir- 
arsyl and said to be the active reduction product of 
Atoxyl. Ehrlich introduced it after he and his as- 
sistants had carried out very extensive pharmacologic- 
al tests with it at the Speyer House in Frankfurt-on- 
(28) (29) 
Main. H. Wendelstadt , Ch. Schilling and 
others found it of great value in certain forms of 
(30) 
trypanosomiasis and in Syphilis. Alt found that 
it relieved patients who had Epilepsy and Paralysis 
due to Syphilis, that it was capable of converting a 
op sitive Wassermann reaction into a negative one, and 
that it had no effect whatever on idiotic children 
with hereditary Syphilis. He noted no secondary 
action, no optic nerve injury, no albumen and no su- 
gar in the urine after its use, but an increase in 
body weight and general improvement in every case. 
(31) 
Lambkin on August 14th, 1908, said that there was 
not yet sufficient time to allow one to express any 
definite opinion regarding its use, that the fact of 
it being supplied in vacuo and the dangers attached 
to it on its exposure to air appeared to him to put 
it out of count for anything like general use, more 
especially as the little glass tubes in which it was 
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supplied were very apt to get cracked in transit, thus 
exposing the salt to the air. 
Neisser(32)in 1908 said that for the present he 
would always combino both drugs (Arylarsonate and Mer- 
cury) either employing them simultaneously or success- 
ively. 
In the same year that this drug was introduced we 
find mentioned the introduction of MERCURY ATOXYLATE 
or MERCURY PARAMIDO- PHENYL -ARSINATE in the treatment of 
(33) 
human Syphilis by Uhlenhuth and Manteufel who as- 
sumed that the combination of Atoxyl with Mercury would 
be sure to prove useful in this disease. They first 
ascertained that the new preparation was efficacious 
for spirillosis in fowls, Syphilis in rabbits, Spiro- 
chaetae of experimental recurrent infection, and try - 
panosomia.sis,and that it possessed a specially destruc- 
tive action on Spirochaetae. Though scarcely soluble 
in water it has been shown by experiments in vitro to 
differ from Atoxyl principally in that it energetical - 
ly destroys trypanosomes and epirochaetae. Blumen- 
(34) 
that in his experiments seems to have shown that 
Mercury Atoxylate (at all events the preparation he 
employed) was more toxic than Atoxyl owing to the ab- 
sorption of Mercury, and that there was no difference 




E. Lesser and Mickley were the first to 
report clinical experiments with this drug in human 
Syphilis. They used the preparation in an emulsion 
of 1;9 olive oil and exhibited it intra- muscularly. 
They obtained very successful results and found that 
°1 gramme (12 grains) was enough to cause papular 
syphilides to fade and papular infiltrations to sub- 
side, that after the third injection usually nothing 
was left of the papular rash except some pigmentation 
without infiltration, and that excellent results were 
obtained in malignant syphilis, ulcers healed and be- 
came clean in a very short time, that it had favour- 
able effectsupon the ulcerous and gummatous cutaneous 
lesions of tertiary syphilis while the patients' 
general conditions improved, secondary effects were 
very slight when it was carefully used, provided that 
the mouth was kept in good condition and the treatment 
was not used in cases where there was injury to the 
eyes. Lambkin(37)gave a detailed description of the 
use of Atoxylate of Mercury in a series of thirty 
cases treated by him at the Military Hospital, 
Rochester Row. The preparation he used was manufac- 
tured by the Vereinigte Chemische Werke A.G. Charlot- 
lenburg (the manufacturers of the original Atoxyl) 
and supplied by Messrs Greef & Co. of London. He 
said, in the paper, that he had not then had one case 
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showing the slightest toxic effects, that all had 
greatly benefitted by it, that under it all the active 
symptoms cleared up in a marvellous way, even more 
rapidly than when Calomel was used. 
After numerous cases treated by me with a 10% 
atoxylate of Mercury cream after the formula of Colon- 
el Lambkin as given in the Lancet, January lst, 1910, 
and procured from Messrs Oppenheimer Sons & Co. of 
London, I can say for certain that I have never in 
any single case observed any intolerance of the drug 
or any toxic symptoms. I may mention that this drug 
is to be given intra- muscularly (and in parts devoid 
of fat as much as possible) and not subcutaneously. 
(38) 
It is interesting to note that E. Mameli and G. Ciuffo 
describe a mercury -para -amido- phenyl -arsinate prepared 
by them, to which they give the name of "aspirochyl" 
and that the results obtained by them with its use are 
claimed to be very satisfactory. 
Dioxy-- diamino- arseno- benzol or Ehrlich Hata "606" 
(also called Salvarsan), the newest and most import- 
ant arylarsonate, was introduced by Ehrlich towards 
the close of 1909 in the treatment of Syphilis and was 
prepared by Dr Bertheim, Ehrlich's experienced fellow - 
worker. In this chapter, I shall deal as far as pos- 
sible and in chronological order with the progress of 
this new preparation from its introduction up to the 
35. 
time of delivery of this thesis. It has perhaps been 
more extensively used than any other arylarsonate and 
hence its literature is almost legion. The most im- 
portant features that occurred in the earliest experi- 
ments on man were: - 
(1) Pain of varying degrees of intensity at 
the seat of injection. 
(2) Increase of temperature never above 38.8 °C. 
(3) A modification of the Wassermann reaction. 
(4) A varying amount of leucocytosis. 
In January 1910, Dr Schreiber (of the Altsder 
Hospital in Madgeburg) recorded his experience in 
twenty -seven cases of well -marked Syphilis, and said 
that the results can without hesitation be recorded as 
most startling. Primary sores showed marked decrease 
in a few days, the hardness, etc. disappearing, and 
that coincidence was quito out of the question for in 
every single case the Specific influence of a single 
injection was quite incontestible. He observed an 
increase in weight among his patients and an altera- 
the 
tion in,Wassermann reaction. The next person to re- 
cord success with this drug was Professor W. Wechsel- 
mann(39)who discovered that it influenced the symptoms 
of Syphilis in all its protean forms with a certainty 
and a rapidity that no other method hitherto known 
can so much as approach, and that cures were so rapid 
that he could not demonstrate the cases, for after a 
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few days there was nothing more to be seen and the 
patients left the hospital. He found that the Wasser- 
mann reaction was modified after a few days of treat- 
ment and that some of his cases that were markedly 
resistant to the long continued use of Mercury and 
Iodide readily yielded to it. Dr Siesskind (profes- 
sor Wechselmann's assistant) found that the spiro- 
chaetae disappeared from the blood in a day, but some- 
times only after several days,while on the second day 
they were swollen and their movements had undergone a 
change. Up to the time of his address on July 4th, 
1910, Professor Wechselmann had not seen any casesof 
recurrence of the disease after treatment. He found 
that the injections themselves were not painful, but 
for days after, there was pain of varying intensity 
which sometimes had to be relieved by narcotics. 
Occasionally, there was pyrexia (varying from 38° to 
nearly 3900.) and oedema of the parts. Professor 
Alt(40)ir_ July 1910 reported favourably upon lecithin 
metabolism following its use. He announced that the 
excretion of arsenic did not proceed as rapidly as 
was maintained by others perhaps on account of the 
intra- gluteal injection becoming encapsulated and so 
its excretion being delayed. He found it especially 
useful in syphilitic icterus (so common in tropical 
countries) and in Epilepsy with a luetic taint and 
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recorded some slight improvement in cases of tabes 
dorsalis. After having tested its efficacy on 150 
cases he concluded that there was never so effectual 
a specific remedy as the new Ehrlich preparation. 
In June 1910, Professor Leonor Michaelis 
(41) 
(Berlin) recorded its undoubted efficacy in two cases 
of malignant Syphilis that had resisted treatment with 
Iodides and Mercur i.ale . 
On June 22nd, 1910, Dr Schreiber (of Madgeburg) 
informed the Berlin Medical Society that he had treat- 
ed 150 cases with Salvarsan both intra- muscularly and 
intravenously and in every case he had observed an 
immediate diminution in the syphilitic signs, and oc- 
casionally a copious exanthema following its use. 
About the same time Dr Heubner found that the symptoms 
disappeared more quickly with intravenous injection 
and that the arsenic was more rapidly excreted. 
Ehrlich(42)himself in 1910 told us that the ar- 
senic was absorbed slowly after antra- muscular injec- 
tion because "a necrosis of the muscle occurs at the 
seat of the injection, enclosing the drug, and dis- 
appearing slowly ". 
Before the Royal Society of Physicians at Vienna 
on June 24th, 1910, Privat -Dozent Doctor Dörr said 
that the instantaneous results after Salvarsan were 
startling and improvement was observed after Mercury 
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and the Iodides had been tried for years and failed. 
On June 30th, 1910, Professor A. Neisser(43) re- 
ported that it exerted a powerful, direct, remarkable 
effect on the Spirochaetes as well as on the syphil- 
itic manifestations, and observed that both in the 
Syphilis of man and animals, the spirochaetae rapidly 
disappeared. He saw so rapid a retrogression of the 
primary sores, of papular syphilides, especially of 
ulcerative processes, and in malignant Syphilis that 
there could be no doubt as to the specific action of 
the remedy. He, however, saw recrudescence which he 
attributed to the dose being too small. Whenever 
possible, he used the intravenous injection and the 
only symptoms he observed were slight pyrexia and pain 
at the seat of injection, and on one occasion a marked 
leucocytosis. 
(44) 
Dr Spatz's experience in a long series of cas- 
es was that the following occurred after its use. 
(1) Pain at seat of injection. 
(2) Pyrexia of varying amount but never ex- 
ceeding 39.20C. 
(3) Frequent headache, nausea and restlessness. 
(4) Urticarial-like cutaneous rashes. 
(5) Polyuria. 
His experience as to the efficacy of the drug is 
also in accordance with those of the preceding phys- 
icians mentioned here. 
39. 
(45) 
The experience of Drs Jeronne and Huggenberg 
in thirty -five cases was that in most of them, al- 
though the lymphatic glands remained swollen, no 
spirochaetae could be found the day after the injec- 
tion either in the primary sore or in the secondary 
ulcerations. The Wassermann reaction was, however, 
an inconstant phenomenon. 
Dr W. Pick, on June 12th, 1910, recorded before 
the Royal & Imperial Society of Physicians at Vienna 
the result of thirty -five cases he had treated, con- 
firmed the expressed opinions that it succeeded where 
Mercury and the Iodides had (after fair and prolonged 
trial) proved useless, and that in most cases the 
symptoms disappeared "with greater rapidity than had 
ever been found with any remedy ", and that with the 
rapid disappearance of the symptoms, there was infre- 
quently in a few days a marked increase in weight. 
On June 23rd, 1910, Professor Treupel(46)communi- 
Gated the results of 500 cases treated till then at 
the Royal Institute for Experimental Therapeutics at 
Frankfurt -on -Main . He recommended that the drug be 
used when the diagnosis of Syphilis or meta -syphilis 
be made by the best available means, that is, the 
Wassermann reaction and the examination of several 
lumbar punctures (Nonne -Apelt method) or when recrud- 
escencesrepeatedly occurred, despite mercurial treat- 
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ment by the most approved methods, and there was per- 
haps some strain of spirochaetae resistent to Mercury, 
and that intra- muscular injections should be employed 
on account of the guarantee of a prolonged action of 
the arsenic in view of its slower excretion. As re- 
gards the effects of the remedy, he said that the 
specific effect upon the syphilitic rash, papules, 
ulcers and mucous membranes was undeniable and that 
the cures were so rapid that the cases soon passed out 
of sight. He, however, considered that it was too 
early to give any reply as to the question of the dura- 
tion of the cure, and that the phenomenon of the Was- 
sermann reaction was inconstant. 
(47) 
Drs ßohae and Sobotka , however, on July 25th, 
1908, reported alarming symptoms following its use. 
Among the symptoms recorded by them were the fol- 
lowing: - 
(1) Retention of urine, lasting for more than 
half a day. 
(2) Absence of the patellar and some other 
reflexes. 
(3) Rectal tenesmus with obstinate constipation. 
They, however, despite these symptoms, were able 
to confirm the views already largely expressed as to 
its curative power. 
Several ascribed these latter alarming toxic 
symptoms to the methyl -alcohol which they used to 
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dissolve the Ehrlich-Hata preparation. They, however, 
deny this, and recorded cases of recurrence of syph- 
ilitic symptoms after its use. 
On August 1st, 1910, Schreiber & Hoppe(48)recor- 
ded very quick results obtained in 120 cases that were 
treated by the intravenous method. 
(49) 
On July 31st, 1910, Hoffmann (Bonn) reported 
very good results in many cases. He observed a few 
recurrences and warned us that with the new remedy we 
were "not to forget the value of increasing doses of 
Iodides and injections of Mercury in Malignant Syph- 
ilis". 
On August 8th, 1910, Privy Councillor Professor - 
Doctor A. Neiseer(50)stated that in the 2,500 cases 
which by then had been treated, there was only one 
case of really serious organic disturbance which could 
with certainty be attributed to the drug, the effects 
surpassed anything hitherto seen, even in the most 
striking result obtained with Mercury or the Iodides, 
and that lesions of primary and secondary Syphilis 
rapidly disappeared. The spirochaetae also rapidly 
disappeared while recurrences were observed in five 
cases which were treated with insufficient doses. 
He did not fear that with repeated injections the germs 
would become arsenic proof, advised local treatment 
as well, and that it should be employed where Mercury 
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could not be tolerated or had no effect. He was con- 
vinced that the position was so far assured that we 
must now advise every syphilitic, when no special con- 
tra- indications exist, to try the new remedy. 
(51) 
Dr Wechselmann after an experience of 503 
cases said that there was almost without exception an 
increase in weight, and a remission of the night pains 
of Syphilis in bones, while recurrent cases quickly 
yielded to a second injection. He raised the ques- 
tion as to whether certain strains of spirochaetae 
were arsenic -proof and recorded marked amelioration 
of symptoms in tabes dorsalis of syphilitic origin. 
Ehrlich(52)had no case of blindness to record up to 
August 12th when 4,000 cases had been treated and 
said that a complete cure was possible in man in 90% 
of the cases. 
( ) 
On August 18th, 1910, Professor H. Herxheimer 
recorded the result of extensive personal experience 
and endorsed all the good qualities claimed for the 
drug. He said that compared with Calomel injection, 
the verdict was in favour of arsenobenzol. He re- 
garded heart diseases, optic nerve anomalies and 
bronchiectasis as contra -indications, and advised 




On August 15th, 1910, Dr H. Isaac reported 
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that "there was an incomparably prompt, often rapid 
and complete action of the drug upon the spirochaetae 
and upon the re- absorption of the pathologico- anatom- 
ical changes there present ". 
(55) 
In seventy-one cases treated by Michaelis , he 
had never seen any untoward results. 
Dr Heinrich Loeb(56)on July 26th 1910 reported 
that after a single injection, we obtained the same 
results formerlyobtainable after months of mercurial 
inuncticns or injections. 
(57) 
On August 16th, 1910, Iversen of St. Petersburg 
announced that the "Ehrlich -Hata remedy could bring 
about the disappearance of the sym t olla of Syphilis 
in the shortest possible time." 
(58) 
On August 22nd, 1910, Professor Kromayer in 
describing the results of his cases recommended the 
treatment by the old and newer remedies in ordinary 
cases, "606" alone when Mercury cannot be supported, 
and for the treatment of the chancre before there was 
any secondary symptoms. 
Mr J. E. R. McDonagh(59)in describing twenty 
cases treated by him concluded that there was no doubt 
that by Ehrlich's genius the greatest victory over 
Syphilis had been obtained. In these cases also 
there was general improvement in the patients' con- 
dition. On September 17th, 1910 (p.793) the corres- 
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pondent of the British Medical Journal at Budapest 
gave abstracts of a few cases published in the 
Gyogyaszal which showed that Ehrlich's drug acted 
quickly in the different stages and manifestations of 
Syphilis .... The most striking feature was that 
severe cases and those which did not react to mercury, 
quickly and surely responded to the new drug. 
McDonagh ( "The aetiology, treatment and pathology 
of Venereal Diseases as we see them to -day, with spec- 
ial reference to '606'" - Practitioner, November 1910) 
said that a new drug called dioxy- diamino -arseno -ben- 
zol was engaging everybody's attention, and that its 
aim was not only to cure Syphilis after one injection: 
but also to prevent any recurrences and that under its 
use lesions disappeared in a marvellous manner, while 
James McIntosh (Lancet, September 3rd, 1910) expressed 
the opinion that the new product was the outcome of 
painstaking research on the part of Ehrlich & Dr Bert - 
heim, it was a substitution product of Atoxyl, it was 
in the highest degree parasitotrop without being or- 
ganotrop, that the protozoa were destroyed before they 
had a chance of developing immunity to the remedy, 
and that marvellous results were obtained without the 
least ill effects. 
Knuthsen (00 )remarked that the discovery of "606" 
was no mere chance but was due to a series of experi- 
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ments scientifically and admirably carried out with 
scrupulous care and attention and exploited quietly 
and unostentatiously with care and patience by a great 
star and his satellites. 
In the Lancet of September 3rd, 1910, Dr J. E. R. 
McDonagh gave a report of twenty cases treated by him 
with "606 ". He remarked that the earlier the Syph- 
ilis, the larger the dose required (.45 to .6 gramme) 
and that 3 gramme was ample in the late stages. He 
observed in every case a marked improvement for the 
better, that the severer the case the quicker the ac- 
tion of the drug, that the results so far obtained 
were beyond one's expectations,and that we were on 
the right road to find an absolute cure for a disease 
which is a curse to mankind. 
The same author (in "Further experience with 
'606", Lancet, October 22nd, 1910) recorded cases of 
malignant Syphilis resistant to Mercury readily yield- 
ing to the new preparation, and that after an injec- 
tion, the Wassermann reaction had a tendency to become 
negative. He records twelve deaths (most of which 
occurred after the drug had been given as a last re- 
source) in 12,000 cases that were treated. 
46. 
THE CHEMISTRY OF THE ARYLARSONATES. 
Arsenium is a metalloid and from its physical 
and chemical properties has been included along with 
antimony, sulphur and a few other elements in the in- 
organic group of chemical substances. It is poly- 
valent and thus is included both among triads and 
pentads. It also forms two classes of compounds, 
viz. arsenious and arsenic. Despite the fact that it 
is an inorganic substance, it nevertheless lends it- 
self to the formation of organic compounds. Although 
itself a poison - and forming compounds with varying 
degrees of toxicity - its derivatives are sometimes 
used externally; while internally,it is extensively 
used in various pathological conditions. In recent 
times the pharmacological action of arsenic and its 
salts has been thoroughly worked out and the thera- 
peutic indications of the organic salts are now well 
defined. Further and more recent investigations, re- 
sulting in the introduction of its organic salts, 
mark a great advance in the knowledge of the subject. 
The great interest of these organic preparations lies 
in the fact that much larger quantities of arsenic 
can be administered when given in the form of an or- 
ganic salt than was formerly possible and its remedial 
efficiency is consequently enhanced. 
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Arsenic Acid or Ortho- arsenic Acid. As 0(OH)3, 
it was found, could have one or more of its hydroxyl 
(OH) radicles replaced by an organic group with a 
greater or less reduction of toxicity, according to 
the nature and extent of the substitution. 
When one of these OH or hydroxyl groups is re- 
placed by an organic radicle (such as Methyl (CH3)), 
the resulting compound is an Arsonic Acid and its 
salts are called arsonates. When two such groups 
chango places, the product is an Arsinic Acid and its 
salts are arsinates. 
An arylarsonate is an aromatic or benzene arson - 
ate; Aryl indicating phenyl, tolyl, xylyl or naph- 
trial, etc. as applied to substituted hydroxyl in 
arsenic acid. When the substituted hydroxyl belongs 
to the fatty or paraffin series such as methyl, ethyl, 
etc. the arsenic acid becomes an alkylarsonic acid 
and its salts are called alkylarsonates. Bearing in 
mind what an arylarsonate is, we find that in the case 
of Atoxyl and Soamin, the aryl radicle is aniline 
coal -tar derivative. 
I may summarise the preceding as follows: - 
(1) Arsenic Acid = As 0 (OH)3 , and its salts 
are arsenates. 
(2) Replace one of the OH or hydroxyl groups by 
an organic radicle as Methyl (CH3) and this 
becomes an arsonic acid, e.g. 
CH3 As 0(OH)2 = methyl -arsonic acid. 
48. 
(3) Replace two such groups and we have an ar- 
sinic acid. Thus (CH3)2 As 0 OH = di- 
methyl arsinic (or cacodylic) acid. 
From experiments carried out by Professor Fraser 
of Edinburgh we know that sodium cacodylate (an or- 
ganic preparation of arsenic) is excreted as such and 
is far less toxic than inorganic arsenical salts such 
as sodium arsenate, etc. More recently another com- 
pound,still less toxic than the cacodylates, was pro- 
duced by heating arsenic acid with aniline. This 
product is called Atoxyl. In this chapter. I pro- 
pose to deal chemically and in the same order with 
the arylarsonates already mentioned in the historical 
section. 
When Atoxyl was first discovered, it was supposed 
to be a direct compound of arsenic and aniline and was 
termed meta -arsenic anilide which name we now know to 
be wrong. Later on, it was called Anilarsonate which 
is also a misnomer as the compound contains no anil- 
ine. It is really an arsonate of Sodium - the sodium 
salt of an arsonic acid containing the amino -phenyl 
group in place of one of the OH groups. 
Thus Amino -phenyl Arsonic acid is (C6H4 NH2) 
As 0(OH)2 and its sodium salt is (06H4 NH2) As O. OH 
ONa which is the correct formula for Atoxyl or 
p- amino -phenyl -arsonate. Its alternative formula will 
be found in the table at the end of this section. 
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The amount of water of crystallisation is inconstant, 
depending upon the method of production and conditions 
of crystallisation thereby causing the quantity of 
arsenium to also vary. 
Fourneau(1), in the substance used by him, found 
two molecules of water of crystallisation. Moore, 
(2) 
Nierenstein and Todd described a product with three 
molecules, and Ehrlich and Bertheim(3)a product with 
four molecules. This last compound constitutes com- 
mercial Atoxyl with 24.12% of Arsenium and crystal- 
lises when special measures are taken, in very refrac- 
tive bold crystals. Its extensive use in trypanosom- 
iasis and protozoal diseases has made it desirable to 
have a definito compound of standard strength - since 
the results obtained by French and German Atoxyl dif- 
fer so widely - and with this end in view, elaborate 
investigations have been taken and various synthetic 
chemical compounds with various definite strengths 
have been used. 
Chemical and Physical properties of Atoxyl. 
(1) A white amorphous, crystalline or yellow pow- 
der when exposed to light. 
(2) Taste refreshing, soluble in six parts of 
cold water and readily in boiling water, with a 
slightly acid reaction. Readily soluble in alcohol. 
Its aqueous solutions are decomposed by light and by 
heating. 
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(3) Often contains parafuchsin, aniline and in- 
organic arsenic as impurities. 
(4) When heated, it slowly decomposes (without 
fusing) and gradually assumes a brown colour. 
(5) On the addition of dilute acids, the free 
acid is precipitated in solid white flakes easily sol- 
uble in excess of mineral but not of acetic acid. 
(e) Insoluble in Ether, Benzol, Chloroform and 
Acetone. 
Tests. 
A 10% aqueous solution of Atoxyl gives with 
(a) Ferrous sulphate solution an olive green pre- 
cipitate. 
(b) Mercuric Chloride solution a white precipi- 
tate. 
(c) Nickel Chloride solutions; at first a 
or white solution, but lat- 
(d) Magnesium Sulphate er on a crystalline pre- 
cipitate. 
Various other coloured precipitates are given 
with solutions of other heavy metallic salte. 
The most sensitive test is the mixture of hypo - 
phosphorous and hydrochloric acids originally intro- 
duced for the detection of arsenic in glycerine, viz: - 
Sodium hypophosphite 1 part 
water 1 " 
Hydrochloric Acid 10 parts 
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By this test, the presence of 05 milligramme of 
Atoxyl can be demonstrated by the production of a deep 
brown precipitato on warming and thus we can estimate 
the rate and amount of the elimination of Atoxyl from 
the kidneys. If to the mixture of reagent and 
(Atoxyl) solution we add two drops of df.- Iodine solu- 
tion, we can detect 92 milligramme of arsenic acid. 
SOAMIN to all intents and purposes is a pure form 
of Atoxyl with five instead of four molecules of water 
of crystallisation. Thus Amino -phenyl arsonic acid 
(as we have already seen) is C6H4 (NH2) As 0 (OH)2 
and its sodium salt is C6H4 (NH2) As 0 (OH) (ONa); 5H2 
which is also the formula for Soamin. The table at 
the end of this section will show at a glance the fur- 
ther differences between it and Atoxyl. 
(1) It is soluble in five parts of water at 60 °F 
and in three parts of water at body temperature, giv- 
ing a neutral solution which can be sterilized by boil- 
ing - without undergoing decomposition - for five min- 
utes. 
(2) It contains 22.8% arsenium with 1/40 the tox- 
icity of Arsenious acid. It is a pure and stable 
salt. 
Arsacetin or Sodium Acetyl- Arsanilate. 
This is derived as follows:- Para- amino -phenyl- 




amino -phenyl -arsonate whose sodium salt is called 
Arsacetin with a formula as follows: - 
This formula, according to Martindale, is 
C2H30. NH. 06H4. As O. (ONa) (OH) ; 5H20 
According to E. Merck's Annual Report, 1908, 
Vol. XXII. page 132, its formula is 
OH 
CH3. CO. NH. C6H4. As ̀ F- a 0 (+ 3 or 4 H20) 
`ONa 
Properties. 
(1) It is a white crystalline powder, soluble in 
ten parts of cold water and in about three parts of 
hot water. It is readily soluble in Methyl Alcohol. 
(2) It is absolutely free from arsenic and ar- 
senious acid. 
(3) It can be heated to 130 °C for an hour in an 
autoclave without decomposition and its solutions are 
unaffected by boiling. 
Tests. 
(1) 5% Solution of Arsectin equal quantity of 
Liq. Sod. Hypochlor = nil. 
(2) 5% Solution + equal part of Barium Chlor. 
Solution and strong Ammonia = dense crystalline 
precipitate. 
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(3) 5% Solution 4-1Y,/10 of K2Mn204 = Red colour, 
no precipitate on boiling. 
ARSENO- PHENYL- GLYCIN or SPIRARSYL. 
This salt has the following composition: - 
Na 00C. CH3. NH. C6H4 - As = As - 06H4. NH .CH3 .000 Na 
or 
(As C6H4 . NH . CH2 . COOH )2 
Properties. 
(1) A pale yellow powder readily soluble in 
water. 
(2) Must be kept in sealed glass tubes, the air 
in which has been expelled, else it is readily decom- 
posed by the atmosphere. 
MERCURY ATOXYLATE (also called Asyphil). 
This is the mercury salt of Para- amino- phenyl- 
arsenic acid. Various formulae are given for this 
preparation. According to E. Merck's Annual Report, 
Vol. XXII. page 142, 1908, its formula is 
NH As 0 0 - " - "'H 
NOH 0H 
According to Lambkin in the Lancet of January 
1st, 1910, in the article "The combined mercurial and 
arylarsonate treatment of Syphilis ", the preparation 
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of Atoxyl and Mercury made for him by the Vereinigte 
Chemische Verke A. G. Charlottonburg was described by 
them (the makers) as the acid mercury salt of Atoxylic 
acid and having the following chemical constitution. 
1- C12H1406N2As2Hg = Empirical formula from analysis 
QH 
2. As 0 
NH2 
Hg 0 Ás 0 
Probable constitutional formula. 
It contains 23.7% of Arsenic and 31.8 Mercury. 
Properties. 
(1) A white crystalline powder with no water of 
crystallisation. 
(2) Practically insoluble in water. 
(3) It assumes a pinkish tinge when heated to 
1000C. 
(4) Its solution does not precipitate albumen. 
DIOXY- DIAMIDO -ARSENO -BENZOL (Salvarsan) or Ehrlich - 
Hata's preparation "606 ". 
The formula for this, according to Dr Bresler is 
012 H12 02 N2 As2 
It was prepared by Dr Bertheim, Professor Ehrlich's 
co-worker. 
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Its formula, according to McDonagh(4)is graphic- 
ally as follows, and it has for its basis p- oxyphenyl- 
arsonic Acid which can be prepared by acting upon 
Phenol with Arsenic Acid. 








expresses the formula as follows:- 
OH i OH 
NH 
As = As -----C 
H2 
After being prepared for use (usually by way of 
intra- muscular injections) the new formula (according 
to Knuthsen) reads as follows:- 
OH 
06H3 ---As = As---06H3 
H Na 
OH C 1 
Properties. 
(1) A bright yellow powder put up in hermetically 
56. 
sealed bottles filled with an enert gas to prevent 
oxidation. It is slowly but completely soluble in 
water, with a strongly acid reaction. 
(2) Only stable as a bichloride but since it is 
not to be injected in the double salt forms, it is 
converted into a mono- or bi- sodium salt by the ad- 
dition of Sodium Hydrate just before use, which,being 
unstable, must invariably be employed fresh. "606" 
that has become discoloured - either grey or brownish 
- must not be used. 
Resume and table showing some of the leading 
features of this section at a glance. 
Atoxyl, Soamin, Arsacetin and Arseno-phenyl- 
glycin all contain sodium. 
Mercury Atoxylate and Salvarsan (Ehrlich -Rata 
"606 ") are not substances containing sodium except 





Sodium p- amino- 
phenylarsonate 
Chemical Formul Structural or Graphic Formula. 
0 6H7N As 03 Na; 4fi20 (C6H4NH2) As 0 (OH) ONa , 4 H20 
Soamin Sodium para -amino- CH7N As 03Na, 5H0 
Areacetin 
phenylarsonate 
Sodium Acetyl -Arsanilate 
or 
Sodium p- Acetyl- 
Amino- phenylaréinate 
C8H9 N As 04Na 
- 5H20 (Martindala) 
or 3 or 4 H20 (Merok) 
Spirarsyl Arseno- phenyl- glycin 
Asyphil Mercury p- Amino -- Phenylarsonate C12H1406N2 Ast Hg 
Salvarsan Dioxy- diamino- arseno -benzol C12H1202N2 




As O. OH. Na0 - 4H20 
(C6H4 NH2) As 0 (OH)(0Na); 5H20 
or 
OH 
NH2C6H4 As 0, 5H20 
ONa 










1- 3 or 4 H20 (Merck) 
(Na00C. CH3 NH. 0 6H4As)2 
(NH2 - 06H4. As O. OH. 02 Hg 
= As 
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The following is a table showing the Arsenic 
value of these preparations. 
(1) Atoxyl with four molecules 
of water of crystal- 
lisation. 
24.12% Arsenic 
(2) Soamin 22.8% Arsenium 
(3) Arsacetin 20.2% Arsenic 
(4) Arseno-phenyl-glycin 33Z8;ß 
(5) Mercury Atoxylate 
(6) Ehrlich-Hata "606" or 





At the commencement of this chapter, I pointed 
out that Arsenium was a triad as well as a pentad. 
Ehrlich(6)has pointed out the "parasitotropìc" 
importance of the unsaturated trivalent Arsenic - 
such as we see in the formula for "606" which is ac- 
cording to Martindale and Westcott 
C - As = As - C n 
HC CH HC CH 
I 
I I 1 
HCl . H2N. C` 
/CH 
HC CC NH2 HCl . 
V v 
C .oH C.OH 
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The arsenic is also trivalent in Arseno- phenyl -- 
glycin. It is, however, nentavalent in Atoxyl, 
Arsacetin, and some other compounds (Cacodyl). 
The value of trivalent as compared with op nta- 
valent arsenic in therapy, I shall refer to at the 
end of the next section of this work. To convey some 
idea of the laborious nature of the researches lead- 
ing up to "606 ", it is statod that almost 200 deriva- 
tives of Phenylarsonic Acid had to be prepared, exam- 
ined biologically, and tried therapeutically subse- 
quent to Arseno- phenyl- glycin, which had the number 
418, before the most active No. "606" had been syn- 
thesised. 
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THE PHARMACOLOGICAL ACTION AND THERAPEUTIC USES. 
Before passing on to discuss in this section of 
my thesis the various theories as to the modes of ac- 
tion of the arylarsonates in vitro and in corpore and 
to point out their indications and contra -indications 
in various pathological conditions, it would be well 
F 
if I were to preface it with a few general remarks on 
the action of drugs in protozoal diseases and to men- 
tion a few additional facts which I purposely omitted 
in the Chemical Section of this thesis. 
Protozoa are more susceptible to the action of 
drugs than bacteria because they are less highly or- 
ganised, are not provided with a cell -wall of much 
significance, and their protoplasm is for the most 
part motile. 
Ehrlich has long since pointed out that a drug 
can only be of value in infectious diseases if taken 
up more rapidly by the parasites - "bacterio- tronous" 
(aetiotropus) - than by the organism ( "organotronous "). 
As the result of numerous experiments, it appears 
to be proved that trypanosomes, although killed by 
some arsenical preparation in vitro and in corpore, 
acquire (a fact alleged by some and denied by others) 
in corpore, intolerance to the drug and this is best 
seen when the drug is administered by the mouth. In 
this latter mode of exhibition, the cells of the 
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alimentary canal, after a while, refuse to absorb the 
arsenic, so that it passes out in the faeces unab- 
sorbed. This, therefore, means that the intestinal 
epithelial cells become immune to its action and it 
no longer reaches the trypanosomes in the blood. If, 
however, the drug be injected subcutaneously or in- 
travenously, it produces its ordinary action at least 
for a while. 
The common inorganic arsenical preparations - 
where the arsenic molecules seem to be rather loosely 
combined with the other constituents in the molecular 
compound - (as indicated by their relatively rapid 
elimination by the skin, kidneys and faeces, etc. 
shortly after administration which account for their 
relative toxicity) when compared with the arylarson- 
ates as a group stand out in bold relief. In the 
latter group the arsenic radicle is in such close 
chemical union with the other constituents of the com- 
pound that elimination is said to begin relatively 
longer after administration, proceeds more slowly and 
is of longer duration. 
Again, when the arsenic radicle in the latter 
group is broken up in contact with the living tissues, 
nascent arsenic is set free and is in a very potent 
chemical condition. 
The phenomena of slow elimination and its com- 
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paratively long duration is the result of a co- opera- 
tion between the living tissue and the drug and en- 
ables us to introduce far larger quantities of organic 
arsenic with comparative impunity when contrasted with 
the same element in its inorganic combinations. 
I may mention here that although we may know 
quite well the chemistry of the arsenic body we intro- 
duce, we do not understand the protoplasmic molecule 
with which it is brought into contact. Furthermore, 
the arsenic contents (of the arylarsonates) do not 
necessarily act as guides to their posology. 
Atoxyl was the first arylarsonate used in the 
treatment of Syphilis and many eminent authorities 
have investigated its pharmacological action, pointed 
out its therapeutic indications and the various mor- 
bid conditions wherein its use is to be withheld. 
While some consider it as a specific in Syphilis, 
others discard it as being useless. 
Its mode of action which I shall soon indicate 
may be taken as representative of the other bodies in 
the same category. Of course, in Atoxyla.te of Mer- 
cury, we have a combination of the specific actions 
of Mercury and Atoxyl. 
When first introduced into the treatment of 
Syphilis, Atoxyl was supposed to act simply as an in -. 
ternal antiseptic and was thought to kill the para- 
sites in direct proportion to the amount of arsenic 
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introduced. Some experiments made in June 1907 by 
Breinl ; Niernstein seemed to disprove this idea. 
In an attempt to produce an active immunity against 
Nagana, mixtures of atoxyl and trypanosomes were in- 
jected in different proportions, and after different 
periods of contact, with the idea that by increasing 
the amount of trypanosome -infected blood and decreas- 
ing the amount of Atoxyl, and by lessening the time 
of contact, a point might be reached at which virulent 
trypanosomes could be injected with impunity. The 
results obtained were not, however, what were expected. 
Dogs, rabbits and donkeys were used for the experi- 
ments, but invariably after the first injection, even 
after the exposure of the mixture for 45 minutes to 
a temperature of 3700, the animals became infected 
after a normal incubation period. This fact seemed 
to suggest that the action of Atoxyl was not simply 
disinfectant, but was the result of a co- operation 
between the lïving tissues and the drug as already 
mentioned above. 
Uhlenhuth, Hubner ik Woith(1)in their experimen- 
tal study on the action of Atoxyl on T. Equiperdum 
came to a similar conclusion. They state (p.296) 
"Unsere Meinung geht jedenfalls dahin, dass der 
Chemismus der Atoxyiwirkung, kein zu einfacher ist, 
wie ihn die Theorie der Arsenspaltung supponiert, 
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das vielmehr bein Zustandekommen des wunderbaren 
therapeutishen Effektes die Körperzelle eine ganz 
hervorragende Rolle spielt ." Their experiments were 
divided into two groups, the action of Atoxyl and 
similar compounds (Sodium arsenate, Acetylated Atoxyl, 
Benzoylated Atoxyl, Benzoyl -acetyl- atoxyl, Sodium -p- 
Hydroxy- Phenyl- Arsenate) on serum proteid being stud- 
led 
(1) In vitro 
(2) In vivo. 
From these experiments it was made respectively 
clear that a combination took place between the pro- 
tein and 
(1) Atoxyl 
(2) Mono- benzoylated Atoxyl 
(3) Mono- Acetylated Atoxyl, 
whilst no combination occurred respectively between 
these proteins and 
(1) Sodium Arsenate 
(2) Acetyl -benzoyl- Atoxyl 
(3) Sodium -p- Hydroxy- phenyl- arsenate. 
The treatment of trypanosomiasis by the above 
mentioned arsenical compounds also differ. Whereas, 
Atoxyl and Mono- acetylated Atoxyl act promptly on the 
parasites, the effects of sodium arsenate is less 
pronounced, that of Sodium- p- hydroxy- phenyl- arsenate 
is nil. 
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The analogy between the way in which these com- 
pounds behave with protein, and their action on try- 
panosomes, is very suggestive. We are, hence, led 
to believe that this combination with the proteins is 
of importance in the trypanocidal drugs, and have now 
to consider how Atoxyl and its derivatives become at- 
tached to the proteins. 
Many protozoa we know take up dyes, e.g. Trypan 
Red is active against trypanosomes. Now, Ehrlich(2) 
has compared the action of a drug to that of a dye. 
We know that it is necessary for a dye to possess a 
chromophoric group - a chemical radicle which causes 
it to be a colour - and a chromogenic group which 
renders it a dye. This is easily illustrated by the 
following examples. 
Azo- benzene (06H5N = NC6H5) which contains the 
chromoph N = B, is coloured, but does not possess 
dyeing properties. It only becomes a dye when the 
chromogenic group OH or NH2 enters. 
Similarly, for e2ample, oxyazo- benzene (OH.C6H4N 
= NC6H5) and amino-azobenzene (H2N.C6H4N = NC6H5) are 
dyes. Their dyeing value increases with the number 
of chromogenic groups introduced. For this reason, 
tri- amino- azobenzene (NH2 C6H5N = N C6H5(NH2)2) 
is a much better dye than amino-azo-benzene. 
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When we apply the same theory to the therapeutics 
of Atoxyl, we find that sodium -phenyl- arsenate 
ONa 
C6H5 As 0 OH 
(which has been proved by Plimmer & Thompson(3)and 
also in experiments conducted at the Runcorn Research 
Laboratory not to possess any curative effect) and 
also Sodium- p- hydroxy- phenyl- arsenate 
ONa 
OH. C6H4 As 0 OH 
do not combine with the proteins, whilst Atoxyl 
ONa. 
NH2 C6H4 As 0 OH 
combines with the proteins and acts on trypanosomes. 
Mono-acetylated Atoxyl 
CH3 CONH C6H5 As 0 
ONa 
OH 
combines and is curative, whilst fully acetylated 
and benzoylated Atoxyl 
CH300 




Hence we suggest that in Atoxyl the amino group 
the 
and in Mono- acetylated- atoxy11,mido group play the 
same role as the chromogenic group in a dye. It has 
been pointed out that the action of Atóxyl is due to 
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the presence of arsenic and the advantage of its use 
is that more arsenic could be introduced in the or- 
ganism in the form of atoxyl than in the form of 
sodium arsenate; it might be argued from this point 
of view that the action of atoxyl is as follows:- 
OH 
The atoxyl ( (C6H4 NH2) As 0- ONa attaches itself 
to the proteins; the benzenes (06H5) nucleus is slow- 
ly oxidised by the tissues and the arsenic is set 
free (in a nascent state), so that, when combined 
with the tissues, Atoxyl acts as a storage for effec- 
tive arsenic. 
This, however, is apparently not the case. It 
is well known that Trypan red, Afridol Blue and Afri- 
dol Violet, also Parafuchsin, have an effect on try- 
panosomes comparable to that of Atoxyl. These com- 
pounds do not contain arsenic, but a large number of 
amido groups. 
Further,-Laveran(4)and Thomas a Breinl, have 
found that Sodium Arsenate in combination with Try- 
pan red acts much better than sodium arsenate alone. 
Ehrlich, in his early researches, would appar- 
ently use simultaneously a number of substances, e.g. 
Atoxyl, Parafuchsin, Trypan red, Trypan blue, chosen 
in such manner that their actions are concentrated on 
the parasites - whilst in the organism of the verte- 
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brates they are distributed over several organs - by 
such means he hoped to cure the disease. He sugges- 
ted to combine a potent substance which will kill off 
the bulk of the trypanosomes with a weaker one, which 
will account for the few remaining ones which other- 
wise would certainly cause a relapse in course of 
time. 
We have, therefore, reason to believe that the 
amido group in Atoxyl, and in the above mentioned 
colouring matters, has a specific action on trypano- 
somes, and that in atoxyl the effective part is not 
only the (nascent) arsenic but also the amido groin. 
In other words, Ehrlich explains the action of 
Atoxyl in trypanosomal diseases by the products of 
reduction (of the atoxyl) in the organism, and this 
explanation has led to the administration to the in- 
fected organism of the active reduction products of 
atoxyl (viz. Arseno- phenyl -glycin). How these latter 
compounds act will be dealt with further on in this 
section of the thesis. Levaditi thinks that the re- 
duction product must first combine with albumen, to 
form a tox- albumen before it can act as a trypanocide 
but Roehl(5)disagrees with this view and with that of 
Uhlenhuth who supposes that the parasites must first 
have a definite relation (though an unknown relation) 
to the cells of the body before they can be killed by 
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the substances produced by the cells of the body under 
the action of atoxyl. 
When trypanosomes, affecting the blood of living 
animals, are subjected to the action of atoxyl, they 
are said to disappear from the blood and actually to 
creep through the blood vessels to escape from the 
arsenic only to return again when the drug is stopped. 
The treponema pallidum - the hitherto accepted cause 
of Syphilis - is chiefly a habitat of the blood plas- 
ma. I have, however, sometimes seen them (in speci- 
mens I have examined) in the interior of the erythro- 
cytes, the cell walls of which were ruptured in places 
by the parasite - and this direct destruction of the 
erythrocytes may quite well account for some of the 
anaemia occurring in Syphilis. 
In etperiments carried on in rabbits which were 
injected with Atoxyl, it was found that the atoxyl (or 
its arsenical radicle) occurred chiefly in the serum 
and only to a very slight extent in the erythrocytes.. 
This fact may have some bearing on its therapeutic 
value in some extra- corpuscular haematozoal diseases 
and explain the resistance of intra- corpuscular haema- 
tozoa (like the plasmodium malariae) to the action of 
atoxyl.. 
As stated at the beginning of this division of my 
thesis, some authorities think that trypanosomes (as 
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a class) become tolerant to arsenical preparations 
and that when this property is once acquired it re- 
mains as a hereditary characteristic. Ehrlich, on 
the other hand, thinks that trypanosomes never become 
tolerant to organic arsenic. 
Views - quite contrary to one another - are ex- 
pressed as to the value of atoxyl in Syphilis. 
Can this be due to the possibility that different 
(as yet undifferentiated) treponemata can cause Syph- 
ilis, a disease protean in its aspects, and that some 
yield readily to the action of nascent arsenic elimin- 
ated during the oxidation of atoxyl in the (living) 
tissues, while others resist it and the amido groups 
mentioned above ? 
Atoxyl - especially the earliest preparations 
used in experimental pharmacology and practical ther- 
apeutics - was an impure drug with no then definite 
standardization, and so gave rise to various toxic 
symptoms. Like other arsenical preparations it is 
slowly eliminated, unchanged (it is said) or in the 
form of some of its allied bodies chiefly by the 
kidneys (sometimes giving rise to albuminuria) and 
the bowels. Its toxic effects - when they occurred 
- were not due to aniline, as neither it nor p- amino- 
phenyl-- sulphonic acid is found in the urine after its 
administration, but to the toxic effects of arsenic 
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as such (the characteristic signs of aniline poison- 
ing being absent, and every symptom of death by ar- 
senical poisoning being present). 
The chief toxic action of atoxyl seems to be 
concentrated on visual nerve apparatus. The earli- 
est sign of this is said to be a contraction of the 
field of vision; while numerous cases of optic atro- 
phy and post -bulbar neuritis (already mentioned) are 
authentically recorded. Its use is, therefore, con- 
tra- indicated in Syphilis affecting the optic nerves 
and the central nervous system (it is said). 
Some authorities like Spielthoff(6) regard atoxyl 
in full doses as a specific for Syphilis and Uhlen- 
huth, Sabrazés and Babesch all endorse his views. 
: Others, like Curschmann(7)and Tomasczewski(B) 
found that in very many cases it had no effect what- 
ever upon the symptoms of primary and secondary syph- 
ilis. 
Whatever merits are claimed for it by those who 
advocate its use, it certainly appears to be indica- 
ted in 
(1) Cases which prove to be refractory to 
Mercury after full doses of it. 
(2) Cases of so- called malignant syphilis in 
which the use of Mercury leads to a change 
for the worse in the general condition and 
in the specific symptoms. 
(3) In cases of patients who exhibit a marked 
intolerance to Mercury (administered in 
various ways) by the repeated occurrence 
of mercurial poisoning. 
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(4) In cases of mercurial stomatitis when the 
existence of syphilitic symptoms necessi- 
tates the continuance of a specific treat- 
ment. 
The same remarks applicable to the toxicity and 
other properties of Atoxyl would apply partly also to 
Soamin which in reality is a chemically pure form of 
the same drug with a definite amount of arsenic and a 
fixed number of molecules of water of crystallisation. 
On account, then, of the occasional toxic effects 
of Atoxyl, various other chemical substances belong- 
ing to the same group as it were experimented with 
and in various ways chemically altered to decrease 
their toxicity. Atoxyl by then had been found out 
to be superior to inorganic arsenic in trypanosomiasis. 
It was then chemically modified and various other pro- 
ducts were obtained, the toxicity of which was from 
twenty times lower to sixty times higher than that of 
the original product whilst the antiparasitic action 
on the trypanosomes was unaltered. 
The most favourable results were obtained by the 
introduction of an acetyl radicle into the molecule 
analogous to the previously known favourable result 
of acetylisation of other drugs (acetyl -salicylic 
acid, phenacetin- acet- phenetidin - ). These 
acetyl derivatives are very much less toxic and much 
more stable and resistant to heat than the other 
73. 
derivatives which is a great advantage. 
Some of the most recent investigations of 
Ehrlich(9)are of considerable interest. He discov- 
ered that very dilute solutions of the acetyl deriva- 
tive were sufficient to destroy the trypanosomes in 
corpore but in vitro even high concentrations (l -2 %) 
were ineffectual. He has found the explanation of 
this to be in the fact that the compound was reduced 
in the body and that the reduced product is a much 
more patent trypanocide. He has produced a series 
of substances represented by the formulae and having 
the properties as indicated. 
and 
As = 0 
Oxidised compounds 
Very toxic 
Trypanocidal action in vitro weak. 
As = As 
A Reduced compounds di- molecular 
less toxic. 
Trypanocidal action in vitro very 
NH2 NH2 
strong. 
II() then dealt in his paper with the question of 
the acquired resistance of the trypanosome to drugs 
and stated that the preparation arsenoglycin or 
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arsenophenyl- glycin was active when the trypanosomes 
had acquired resistance to the other drugs. 
Atoxyl, Soamin, Arsacetin and Arseno- phenyl- 
glycin are chemically closely related to each other, 
their pharmacological actions are similar (though 
varying in degree) and their therapeutic indications 
are almost identical. The most pronounced feature, 
however, is their varying degrees of toxicity. Thus 
Soamin (practically a chemically pure and stable form 
of atoxyl) is far less toxic than the original atoxyl 
(a misnomer) and Arsacetin and Arseno -phenyl -glycin 
are both less toxic than atoxyl while possessing the 
same therapeutic action (but in greater degrees) as it. 
Ehrlich(10) Browning(11)and Salmon(12)formd Arsacetin 
three to five times less toxic than atoxyl for various 
animals while its trypanocidal action - as indicated 
above - was greater. Experiments with Arsacetin 
made by Ehrlich and Browning with animals (mice) in- 
fected with trypanosomiasis have proved that even the 
severest cases which otherwise would result in death 
within a few hours can be treated successfully with 
arsacetin, whereas Arsanilate (atoxyl) even in very 
slight infections, had hardly any effect. 
Experiments on various other species of infected 
animals ( trypanosomiasis as well as other protozoal 
diseases) have given excellent results throughout so 
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that the introduction of this product into thera- 
peutics as a mode of treatment for the human being 
seems rational and fully justified, if any importance 
at all can be attached to experiments on animals. 
With regard to the application of arsacetin for the 
treatment of human Syphilis, we have accounts of ex- 
periments made by Privy Councillor Professor Doctor 
Neisser of the Breslau University Hospital for Skin 
Diseases. 
At the 10th Congress of Dermatologists held on 
the 9th June _ 1908 in Frankfurt-on-Main , Neisser 
spoke on this subject and in his account laid down 
the following principles. 
XVII. "In the arsenical treatment of the human 
being, of the products which now merit consideration, 
the principal one is the Acetyl compound of Atoxyl 
(= Arsacetin, Ehrlich). While possessing at least 
anequal degree of curative power, this product is 
much less poisonous than the original Atoxyl. More- 
over, it is stable and its solutions can be steril- 
ized by heat Apart from digestive troubles oc- 
casionally in women no other bad effects have been 
observed." 
XVIII. "It would be wrong, however, to give up 
the well established treatment by Mercury in favour 
of Acetoxyl (= Arsacetin) - the efficiency of which 
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in cases of Syphilis in man is not yet sufficiently 
well established except in those cases where Mercury 
cannot be tolerated or has lost its effect (Mercury - 
proof spirochaetaet)." 
Arsono- phenyl glycin has also been extensively 
used and found to be efficacious in the treatment of 
human Syphilis. Its elimination is slower than that 
of Atoxyl and Arsacetin and it is excreted by the 
bowels in greater quantities than is the case with 
the two latter preparations. Ehrlich thinks it acts 
on that part of the trypanosome which is concerned 
with multiplication. 
Under its use the Wassermann reaction in most 
cases became negative and when not so, it was render- 
ed appreciably less intense. In the following sec- 
tion of this thesis, I shall have occasion to refer 
to this arylarsonate. 
In Mercury Atoxylate largely used in this coun- 
try by Colonel Lambkin who highly recommends it 
(Lancet, January 1st, 1910) we have besides the 
specific action of this arylarsonate, the simultane- 
ous action of Mercury one of the oldest drugs used in 
the treatment of human Syphilis. 
The latest and without doubt the most potent pre- 
paration extant in the treatment of Syphilis in its 
protean aspects is Salvarsan or Ehrlich -Hata's pre- 
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paration "606 ". Its action is very rapid and it is 
said to have completely cured Syphilis even after one 
full injection: It greatly modifies the Wassermann 
reaction and has been very extensively used on the 
Continent of Europe, in England and elsewhere. As 
the result of this extensive use, the contributions 
to its literature and its therapeutic indications are 
very numerous. Among the peculiar phenomena observed 
after its use are:- 
(1) The Herxheimen reaction which consists in an 
increased reddening and swelling of pre -existing ma- 
cular and papular rashes. This reaction may be due 
to a direct destruction of the spirochaetae with a 
consequent setting free of endotoxines or to some 
kind of stimulus imparted to the spirochaetae with a 
more copious secretion of toxic matter. 
(2) A leucocytosis which in some cases was very 
intense. In one of Neisser's cases this amounted to 
38,000 which was slowly reduced. 
I take this opportunity to mention that in Syph- 
ilitic affection (at all events in some of its phases) 
we find a leucocytosis in varying degree. In speci- 
mens of blood examined by me the mononuclear blood 
cells (embryonic or plasmatic cells) were much in 
evidence while a few polymorphs were also found. 
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(3) Pyrexia - where the temperature rose to 
38.50 or 390C. It may be useful to know that when 
we administer Salvarsan to healthy people, there is 
no rise of temperature observed. The pyrexia thon 
may be due to a reaction between the endotoxines (set 
free by the lysis.of the spirochaetae under the influ- 
ence of the drug) and the infected organism. 
I take this opportunity to mention that I have 
extensively used Atoxyl, Soamin, Mercury Atoxylate 
and Salvarsan and the following are some of my ex- 
periences with these various drugs. 
(1) After Atoxyl injections, there was at first 
an exaggeration of the appearance of all syphilitic 
rashes and eruptions, and very often, where there was 
no pre -existing rash, it often produced a peculiar pa- 
pular, scaly eruption of its own. 
(2) Soamin, in some of my cases, gave rise to 
marked urticaria, headache, sickness, abdominal pain, 
rigors and suppression of urine which ceased as soon 
as the drug was discontinued, only to start again on 
further medication. 
(3) Atoxylate of Mercury in my cases gave rise 
to a hard painful induration - perhaps due to encapsu- 
lation of the atoxylate cream I used and its subse- 
auent slow absorption - which persisted for days and 
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even weeks at the site of the injection. There oc- 
curred also in numerous cases marked cutaneous erup- 
tions of an urticarial type. 
(4) Besides pain (of varying intensity and dura- 
tion) at the seat of injection, I observed no untoward 
phenomena with Salvarsan. 
(13) 
Dr R. Sieskind , as the result of numerous 
cases treated with this drug at the Virchow Hospital 
at Berlin,came to the conclusion that it is indicated 
in the following conditions: - 
(1) Cases of malignant and early ulcerative 
syphilis, especially those resistant to 
Mercury. 
(2) Cases where Mercury cannot be tolerated. 
(3) Cases where, despite full mercurial treat- 
ment, recrudescences are frequent. 
(4) Cases of primary sores before the secondary 
rash, preferably with the excision of the 
chancre or its treatment by Hollander's 
hot -air method, together with local injec- 
tions of quite small quantities of "606 ". 
(5) Tuberculous syphilitics who support Mercury 
so badly. 
(6) Visceral Syphilis and patients with epilepti- 
form attacks. 
(7) Decrepit persons, when the eyes, heart and 
lungs are sound. 
(8) Latent Syphilis, when no negative Wassermann 
is obtainable after treatment by Mercury and 
the iodides. 
(9) Parasyphïlis in the first stages. 
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Its use is contra -indicated in 
(1) Serious non -syphilitic diseases of the 
retina and optic nerve. 
(2) Severe diseases of the circulatory system. 
(3) Severe diseases of the respiratory system 
other than tuberculosis. 
(4) Severe non -syphilitic kidney diseases. 
(5) Progressive degenerative diseases of the 
central nervous system. 
Professor Ehrlich himself has told us that the 
main contra -indication is cachexia. 
With regard to its use in children, Professor 
W. Wechselmann advises that only children with fault- 
less nutrition should be submitted to treatment by it. 
He thinks it possible "that in the rapid solution of 
the enormous masses of spirochaetae so large a quan- 
tity of endotoxines is set free as to cause some tem- 
porary harm which the weakly organism of the child 
cannot overcome ". 
This last quotation by Professor W. Wechselmann 
gives us then the key to the action of Salvarsan. 
Under its influence, the spirochaetae become 
swollen, their movements become less active and fin- 
ally agglution occurs (and in specimens I have seen, 
this occurs almost invariably around a leucocyte). 
Lysis of the micro-organisms then occurs with the 
setting free of enormous quantities of endotoxines 
which some believe are really the curative agents. 
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That this is so, seems to be proved by the fact that 
when syphilitic mothers give birth to children who 
show all the usual manifestations of the disease and 
are themselves (the mothers) injected with Salvarsan, 
there is a rapid retrogression of the children's 
symptoms when suckled by the mothers in spite of the 
fact that no Salvarsan is excreted by the milk. What 
then is curative for the infants are the endotoxines 
set free in the mothers' organisms and conveyed to 
the children by way of the breast milk. 
Karl Greven(14 
) 
of the Pharmacological Institute 
of the University of Bonn, has examined the question 
of the excretion of "606" in the urine both in men and 
in rabbits. His conclusions are that 
(1) The excretion commences very early (depend- 
ing on the mode of introduction of the 
drug . into the system). 
(2) The excretion is of longer duration than has 
hitherto been stated. 
(3) It terminates rather earlier after subcut- 
aneous than after intramuscular injections. 
(4) Mercury given simultaneously appears to re- 
tard the excretion of arsenic in the urine, 
whilst iodide of potassium shortens the 
duration of its excretion. 
When after injecting Salvarsan, a. Jarish- Herx -- 
heirmer reaction was found, Wechselmann considers it 
probable that the dose employed was too small to kill 
all the spirochaetae, and regards the reaction as the 
expression of a biological stimulus by too small a 
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dose. Of course a second dose can be tried, but it 
may give rise to symptoms of excessive reaction, or 
it may be useless on account of the spirochaetae be- 
coming Salvarsan- proof: In the latter case Mercury 
could be subsequently employed to destroy any remain- 
ing spirochaetae. 
It has been held by some observers,and to me it 
seems to be the case, that there are strains of Mer- 
cury-proof and arsenic -proof spirochaetae: 
Many and diverse views are expressed as to the 
diagnostic value of the Wassermann reaction in rela- 
tion to the cure of Syphilis. Some hold that a posi- 
tive Wassermann reaction points to a manifest or la- 
(1Z) ) 
tent syphilitic infection, others like Pick say 
that the Wassermann reaction is not affected by the 
remedy ( "606 "). Thus all the symptoms of the disease 
may disappear after injections of Salvarsan while the 
blood may still show a positive reaction. Neisser 
found after the use of Salvarsan that a negative re- 
action was obtained in 44% of his cases, Stern in 
19.2%, Schreiber in 80% to 90 %, Jéronne in 60%, while 
Wechselmann in nearly 100 %! 
In the examination of the blood of pregnant wo- 
men suffering from Syphilis, it would be well to as- 
certain if the Wassermann reaction is not obscured by 
the placental secretions:. Perhaps also the exhibition 
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of too small a dose of Salvarsan does not modify the 
Wassermann reaction: 
I conclude this chapter by the addition of the 
following table and some further reference to Arsenic 
as promised at the end of part three. 
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muscular and subcutaneous. 
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.5 gramme every other day 
for ten days. After 
fourteen days' interval 
repeat the dose if neces- 




in corpore and 
in vitro. 
Ditto. 
A more rapid des - 
tructive agent 
than any of the 
preceding ones., 
A most rapid 
destruction occurs 
in vitro and 
in corpora. 
10 grains of Soamin at 
each injection on al- 
ternate days till 100 
grains are given. Re- 
peat if necessary. 
About 20 injections of 
9.26 grains each. Re- 
peat after an interval 
if indicated. 
Dose not to exceed 15 
grains. To be used 
with caution after other 
arylarsonates. 
á to 12 grains at cer- 
tain definite 
periods. 
See Lancet, January 1st, 
1910. 
.4 to .8 gramme or more 
intra- muscularly. 
.4 to -6 gramme for 
intravenous injections 
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In the last part of the Chapter on the Chemistry 
of the Arylarsonates, I referred to trivalent and 
pentavalent Arsenic. Let us bear in mind that in 
Sálvarsan and Arseno- phenyl- glycin the Arsenic is 
trivalent while in Atoxyl and Arsacetin it is penta- 
valent. Now, according to Ehrlich, pentavalent ar- 
senical compounds should take a secondary position in 
spirillocide power, the reasons given being that 
"large doses of them are necessary, they are not very 
active, and further, that there is danger of optic 
atrophy." 
The Wassermann reaction so often referred to by 
me is also known as the Wassermann -Neisser -Bruck 
blood serum diagnosis or reaction. 
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THE VARIOUS ARYLARSONATES DISCUSSED SERIATIM. 
According to the heading of this portion of my 
thesis, I intend to discuss seriatim the arylarson- 
ates already dealt with in previous chapters and to 
give additional information regarding their use in the 
treatment of human Syphilis. I propose to deal with 
them in the same order as before, and to arrange my 
discourse (whenever possible) on each arylarsonate 
under the following headings:- 
(1) Posology. 
(2) Methods of administration and apparatus used. 
(a) Oral administration. 
(b) Local application. 
(c) Subcutaneous injection. 
(d) Intramuscular injection. 
(e) Intravenous injection. 
(f) Intravenous injection followed by intra- 
muscular injection. 
(3) Its effects on 
(a) Primary and secondary and tertiary Syphilis. 
(b) Hereditary Syphilis. 
(c) Parasyphilitic lesions. 
(4) Its indications and contra -indications. 
(5) Complications occurring during or after its 
administration. 
(6) Phenomena occurring during its use. 
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(7) Elimination of the drug. 
(8) Recurrences after treatment. 
(9) Its effects on Spirochaeta in vitro and in 
corpore. 
(10) Its effects on the Wassermann reaction. 
(11) Its clinical value as far as can at present 
be judged from clinical reports. 
ATOXYL has been administered in different doses 
and in different physical conditions. It has been 
given by the mouth either alone or along with iron 
and quinine salts. 
Alone it is given in tablet form, each contain- 
ing 4 grain of Atoxyl made up with three grains of 
milk sugar. 
In combination with iron, it is given in*two 
forms as follows: -- 
(a) Blaud -Atoxyl Capsules, each containing 
grain Atoxyl and five grains Blaud's pill 
mass at the rate of one capsule twice daily 
for twelve consecutive days, then one week's 
pause, after which again one capsule twice 
daily till 50 capsules have been taken in 
all. 
(b) Atoxyl -Iron Tablets, each containing 4 grain 
Atoxyl and 4 grain lactate of iron. This 
is to be administered at the same rate as 
the Blaud -Atoxyl Capsules. 
In combination with Quinine, it is given in the 
form of a capsule containing the following ingredients: - 
Atoxyl 1/6 grain. 
Quinine Muriato ! grain. 
Strychnine Muriato 1/60 grain. 
Blaud's pill mass 5 grains. 
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and at the rate of one capsule three times daily. 
The oral method of administration is useless 
because the Atoxyl is broken up by the acids in the 
stomach and the drug never reaches the trypanosomes 
in the blood. 
Locally it has been applied to primary lesions 
in the form of a 50% ointment made up with a suitable 
basis. 
The usual, and perhaps the only rational method 
of administration, is in the form of an aqueous solu- 
tion varying from 5% to 10% and injected subcutaneous- 
ly, intra- muscularly or intravenously. To prevent 
pain after injection, a l'% solution of Novocain may 
be added to the Atoxyl solution which must always be 
freshly prepared and kept in brown bottles to prevent 
the action of light on it. The syringe intended for 
use must be sterilised by dry heat or by boiling in 
plain water,and not in acid disinfectants which decom- 
pose the solution. 
Paul Salmon uses a freshly made 10% Solution (and 
a quantity containing 72 to 12 grains of Atoxyl) 
thrice weekly by way of deep intra- muscular injection. 
It has been found to exercise a beneficial influence 
on all forms of primary and secondary specific lesions, 
while gummata rapidly disappear under its administra- 
tion. It has yielded good results in cases of 
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Malignant Syphilis even after Mercury and the Iodides 
have failed. It has no influence whatever on cases 
of hereditary Syphilis while para- or meta- syphilitic 
lesions of the central nervous system are little, if 
at all, directly influenced by it. Its indications 
(already referred to in the last section of this work) 
are those cases where Mercury is contra -indicated, or 
cannot be tolerated, or has been proved wanting. 
The phenomena sometimes observed in connection 
with its use are:- 
(1) Pain at the seat of injection (in some 
nervous people). 
(2) Toxic symptoms corresponding to those occur- 
ring in arsenical poisoning, viz. headache, 
sickness, abdominal pains, weakness in the 
extremities, and dark coloured urine some- 
times containing blood or albumen. 
(3) Optic nerve atrophy (sometimes of sudden 
occurrence) and occasional post -bulbar 
neuritis. 
Apart from these results, the effect of its ad- 
ministration is the causation of a rapid improvement 
in the symptoms. This improvement continues from 
day to day and the patients increase in weight. It 
is eliminated chiefly by the kidneys and faeces, and 
to a lesser extent by the saliva and skin. After its 
use, the disease has been known to recur on several 
occasions. Its effects (compared with other arylar- 
sonates mentioned in this thesis) on spirochaetae in 
vitro are feeble, but in cor ore it has a strong 
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germicidal action. Its effects on the Wassermann 
reaction are inconstant, and its chemical value, as 
far as I can gather from a careful study of a whole 
series of cases, is that though it sometimes succeeds 
where Mercury and the Iodides have failed, it is in- 
ferior to that of Arsacetin, Arseno -phenyl -glycin, 
Soamin, Mercury Atoxylate and Salvarsan. Its use is 
contra- indicated in diseases of the optic nerve and 
retina, and in some non -specific organic diseases of 
the kidneys and liver. People who are old as well 
as those of short stature are said not to tolerate 
the drug. Lambkin(l)thinks that it is a very weak 
prophylactic agent. It does not seem able, as far as 
one may gather from clinical reports, to sterilise 
the host producing Ehrlich's "Therapia Sterilisans 
Magna". 
SOAMIN, the next on the list, has already been 
described as a pure and stable form of Sodium para- 
amino- phenylarsonate. How it differs chemically and 
physically from other arylarsonates, I have already 
mentioned. It has been given by the mouth in doses 
of 4 to one grain one or two hours after food without 
producing toxic symptoms. The maximum daily dose 
for oral administration should certainly not exceed 
three grains, doses greater than which would cause 
toxic symptoms on account of their decomposition by 
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the stomach. It does not appear to have been locally 
used to influence primary lesions. Subcutaneous and 
intra- muscular injections are the best and most fre- 
quent modes of exhibition. The skin should be steri- 
lized (and the same remark applies to all other in- 
jections) before its introduction, and the syringe, 
usually an all glass one with a platino- iridium needle, 
should be boiled in plain water for a suitable period 
before use, to render it aseptic. The usual dose for 
either form of injection is 10 grains dissolved in 
about 60 minims of boiling water. When cool enough, 
the solution should be drawn up into the syringe, and 
injected deeply into the gluteal muscles. Care must 
be taken that there is no hanging drop at the needle 
point when it is about to be plunged into the tissues, 
as it may cause some irritation in the track (of the 
needle). It should be slowly introduced into the 
tissues by firm continuous pressure of the piston, 
the syringe being completely emptied before withdrawal 
when an antiseptic dressing of collodion and gauze 
should be placed over the seat of puncture. The 
( intra- muscular) injection should cause no pain un- 
less a large amount of fluid be introduced, thus caus- 
ing undue stretching of the surrounding tissues and 
the patient should be allowed to rest a few minutes 
after it. For subcutaneous injections, we require 
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very dilute solutions (about 10 grains dissolved in 
not less than 120 minims of water) else very unpleas- 
ant and slightly painful indurated masses remain for 
several weeks after. This is, however, entirely pre- 
vented by adequate dilution. A full course of treat- 
ment by either method consists in 10 grains every al- 
ternate day till 100 grains have been administered. 
The available clinical reports show that it has 
a beneficial influence on the disease, causing primary 
sores to lose their induration and rapidly heal up 
while enlarged glands diminish in size and finally 
disappear. The various secondary symptoms, such as 
condylomata, ulceration of the mucous membranesof the 
mouth, tongue and throat, skin eruptions, night pains, 
etc. soon disappear, while tertiary ulcers rapidly 
heal up. Its action on hereditary lues and para- 
syphilitic lesions is almost nil. 
It is indicated in the following cases: - 
(1) Patients who cannot tolerate Mercury in 
sufficient amount to relieve their symp- 
toms which is most often noticed in cases 
of extensive ulcerations of the mouth and 
throat.. 
(2) Patients who have Syphilis complicated with 
tuberculosis. 
(3) Patients who for any reason cannot or will 
not undergo a long course of mercurial 
treatment. 
Its principal contra -indications are in cases of 
diseases of the central nervous system and optic 
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(non -specific) nerve and retinal affections. 
Sometimes, during its administration, certain un- 
desirable effects - perhaps to be explained on an 
idiosyncrasy to the effects of Arsenic - are observed, 
the principal signs of which are visual disturbances, 
nausea and vomiting, gastric pain, dermatitis, ner- 
vousness and insomnia, the appearances of which are 
a signal for withholding the drug. Toxic symptoms 
are, however, very rare and it has the advantage over 
Mercury in not causing salivation or spongy gums. 
It is eliminated by the same channels as Atoxyl and 
cases have been known to recur after its use. Its 
effects on spirochaetae in corpore and in vitro and 
on the Wassermann reaction are about the same as those 
of Atoxyl. Under its use it was invariably observed 
that there was a rapid improvement in the patients' 
general health with quick retrogression of the symp- 
toms and increase in weight. Its clinical value, 
then, is very great and it certainly is to be preferred 
to atoxyl, on account of its lesser toxicity and the 
rarity of ocular symptoms after its use.. Some ob- 
servers recommend that it should be followed, after 
allowing 15 to 30 days for its entire elimination 
from the body, by a mercurial course. The results 
obtained by it alone, however, are not equal to those 
produced by Arsacetin, Mercury Atoxylate, Arseno- 
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phenyl -glycin and Salvarsan. 
Whether it will ultimately displace Mercury in 
the treatment of human Syphilis, or whether it will 
take a place as an adjunct or alternative to mercurial 
treatment, time and further clinical experience will 
show. What is, however, at present proved beyond 
doubt is that it is of great value in Syphilis and 
some other protozoal diseases. 
Metchnikoff at the Medical Congress at Berlin in 
1907, stated. that with three injections of 10 grains 
each, he had found it, when given at the proper time, 
to act as a prophylactic agent in Syphilis. Lambkin, 
however, (Lancet, August 21st, 1909) did not observe 
this property in the cases that came under his notice. 
ARSACETIN, the next on the list, has also been 
extensively used in the treatment of human Syphilis. 
For oral administration, its dose for adults is 
grain three or four times daily, and for children the 
same dose twice daily. Its external local use is 
not definitely recorded. Although given subcutaneous- 
ly in sterile aqueous solutions containing 72 to 10 
grains of the drug, it is best given in a 10% (aqueous) 
solution intra- muscularly and intravenously with the 
usual necessary antiseptic precautions, while the 
solutions can be boiled to render them sterile. The 
syringe is best sterilised by boiling in plain water 
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and the mode of injection is similar to that in 
(2) 
Atoxyl and Soamin. The dose, according to Neisser 
is 10 grains in a sterile aqueous solution on every 
two consecutive days in each week until twenty injec- 
tions have been given. Under its influence all ac- 
tive primary and secondary lesions rapidly disappear 
(Lambkin(3)) while tertiary symptoms are also greatly 
beriefitted. On hereditary and para- syphilis its ac- 
tion is almost nil. Its contra -indications are al- 
most identical with those of atoxyl and soamin, while 
its indications are the same. It is eliminated by 
the usual channels, but especially by the faeces and 
recurrences have been observed after its use. Neisser 
found that it has a potent parasiticide action and 
that apes, after its use, were incapable of conveying 
the infection. Its effects on the Wassermann reaction 
are inconstant. Besides gastric disturbances in a 
few cases of women to whom it was administered, Neis- 
ser found no secondary ill effects. It is preferable 
to Soamin and Atoxyl, as it is more stable, more pot- 
ent in its action, and less toxic than either. 
Lambkin(4)recommends that it should be followed 
by a mercurial course when this is not contra- indica- 
ted, while Neisser advises us not to neglect Mercury 
in Syphilis until this drug has been more thoroughly 
investigated, and that Mercury and Arsacetin treatment 
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should be combined in a suitable manner. He states 
that he has never seen a case of optic atrophy or of 
similar damage to the nervous system following its 
use and has never observed any renal symptoms. G. 
V) Heymann s opinion is that this substance possesses 
simply a symptomatic action. Among its contra- indic- 
ations already mentioned above, are to be included 
parenchymatous organic lesions. Of the various 
arylarsonates dealt with so far, the weight of clini- 
cal evidence is in favour of Arsacetin. 
T end the discussion of this drug by adding that 
under its administration - and the same remarks apply 
to Atoxyl, Soamin, etc. - the condition of the fundus 
oculi should be constantly examined and the rate of 
elimination of the drug carefully noted by chemical 
quantitative examination chiefly of the urine and 
faeces. 
ARSENO -PHENYL -GLYCIN, the next drug I propose to 
deal with, appears (when compared with Atoxyl, Soamin, 
Arsacetin and the newer arylarsonates) to have been 
very little used in the treatment of human syphilis. 
The one serious obstacle to its more extensive use is 
its ready decomposition on exposure to the air. It 
does not appear to have been administered by the mouth 
or used locally for external primary and other lesions. 
Before beginning treatment by this drug, Alt(7) 
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recommends us to ascertain by means of the ophthalmo 
or cutaneous reaction the susceptibility of the pat- 
ient to the preparation. He administers to strong 
persons on two consecutive days an intra- muscular in- 
jection of one gramme on each day (less robust people 
received .8 gramme). Of the patients treated by him, 
some lost the Wassermann (positive) reaction entirely 
while others did not lose it at all. In some, it be- 
came appreciably feebler only to return later on to 
its former intensity. It has no effect whatever on 
idiotic children with hereditary lues or on para- 
syphilitic conditions. Besides a slight scarlatinal 
rash, a slight rise of temperature, increase of pulse 
rate, vomiting and slight cardiac disturbances, Alt 
did not observe any secondary action of any moment, 
and in none of the cases treated by him was there in- 
jury to the Optic nerve, or albumen or sugar in the 
urine. In every case there was marked improvement 
in the patients' symptoms and general condition, and 
an increase of body weight. Its instability and the 
fact that it has to be kept in vacuo do not hold out 
prospects of it becoming of much use in the treatment 
of human Syphilis. 
In ATOXYLATE OF MERCURY we have a combination 
of the specific action of Atoxyl and Mercury which 
greatly enhances its clinical value. It was intro- 
98. 
duced into practical therapeutics by Uhlenhuth and 
Manteufel() Though scarcely soluble in water, it 
possesses a specially destructive action on trypano- 
somes and spirochaetae which it rapidly destroys in 
vitro,and in this way differs from Atoxyl. It is 
not used by way of the mouth and for obvious reasons 
it is not (being insoluble in water) injected intra- 
venously, while its subcutaneous use is not advisable. 
The only practical method of introduction, then, is 
by deep intra- muscular injection in places devoid of 
fat. 
E. Lesser(9)and Mickley(10) use it in the form of 
an emulsion of 1 :9 olive oil. Men receive a quan- 
tity of this (emulsion) equivalent to 4 grains of the 
drug by way of intra- muscular injection, a second dose 
of the same amount three days later, and a third dose 
of 1.5 grains three days later. This latter dose is 
to be repeated four times at intervals of one week so 
that altogether the patients receive 7Q grains of 
Mercury Atoxylate. The total amount administered to 
female patients is 7 grains, extending over a similar 
period. 
Colonel Lambkin(11)uses it intra- muscularly in 
the form of a creosote, camphoric acid and palmitin 
cream (this cream, containing 10% Mercury Atoxylate, 
is supplied ready for use by Oppenheimer Son a Co. of 
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London) and gives it as follows:- 
Hydrarg Atoxyl 3 i ; vehicle 3 X 
1st injection, r9 vii. = 4 grain Atoxylate of Mercury 
After 3 days, 
2nd injection, vii. = 4 " 
After 3 darn, 
3rd injection, xii . = 
After 7 days, 
4th injection, xii. = 12 " 
and so on until eight injections have been given. 
Allow one month's rest and then repeat the above 
course. 
Under its administration, infiltrationsand all 
primary and secondary lesions rapidly disappear while 
in malignant Syphilis it also gives excellent results. 
Gurnmatóus and ulcerative skin lesions of tertiary 
Syphilis soon disappear while the patients' general 
condition improves from day to day. Lambkin(11)says 
that its rapidity of action is greater than that of 
Calomel. The secondary effects of this drug are 
very slight when it is carefully used, provided that 
the mouth is kept in good condition and the treatment 
is not used where there is any injury to the eyes. 
Lambkin (Lancet, January 1st. 1910) observed (in his 
cases) no toxic symptoms and an increase in weight in 
every case. Although all the symptoms rapidly 
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disappeared, there was no alteration of the Wasser- 
mann reaction, i.e. even under treatment the reaction 
(as a rule) remained positive. 
Albuminuria, as was to be expected, is one of 
the conditions under which it is inadvisable to use 
it. 
I shall conclude this portion of my thesis by 
referring to Salvarsan or Ehrlich- Hata's preparation 
"606 ". It is the latest arylarsonate introduced in- 
to practical therapeutics. 
Posology: 
The average dose is 5 gramme for subcutaneous 
and intravenous injection, but larger doses up to 
even one gramme are advocated by the manufacturers in 
the case of strongly built adult males, according to 
the nature of the case. For women, the average dose 
is .45 to 5 gramme. 
For very weak people .3 to .4 gramme is sufficient. 
For children .2 to 3 gramme and for infants .02 
up to 1 gramme. 
It is not given by the mouth and has been local- 
ly applied to condylomata in the form of a 50% oint- 
ment. 
Methods of Administration: 
(1) Intra -muscular Injection into the gluteal 
muscles. 
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(2) Subcutaneous Injection into the tissues ad- 
joining the base of the shoulder blades. 
(3) Intravenous injection. In this method 
which is said to be painless, the dose is 
given in much weaker dilution, about 200 
to 250 c.c. of diluent being employed. 
(4) Intravenous followed by Intra-musoular in- 
jection to prolong or intensify the action. 
Whatever its mode of introduction may be, the 
solutions must be freshly prepared and the skin at 
the seat of puncture carefully sterilised, while the 
syringe must be boiled in plain water. Various 
patterns of apparatus (modified syringes) are used 
for the different modes of injection. 
Both the intra-musoular and subcutaneous methods 
of injection are apt to be followed by pain of occas- 
ionally such an intense nature that an anaesthetic 
and this is usually 2 c.c. of a 1% solution of Novo- 
cain-- or narcotic may be required. 
The drug in the subcutaneous method is said to 
act moro rapidly and to be more completely absorbed 
in comparison with the intra- muscular method. 
Supplied as it is in the form of a Chloride or 
Bichloride with the formula 012H1002N2 As2 (HC1)2 
with 35.15% of arsenic - and with a strongly acid 
reaction when dissolved in water, it must, before use, 
obviously be treated by an alkali to neutralise its 
acidity. The alkali used isiY /5 or .4710 Caustic 
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Soda (NaHO). If rendered very slightly alkaline - 
almost neutral - the solubility is at its minimum; 
this amount of alkalinity corresponds very closely 
with that of the blood and tissues, and it is probable 
that its relatively low toxicity (in comparison with 
other arsenical preparations) is due to the fact that 
it is so insoluble in the blood. The concentration 
in the blood can never exceed this slight amount and 
Michaelis thinks that no matter in what form the sub- 
stance is introduced, the solubility is never more 
than 1/1000 per cent. 
Its effects on the various primary and secondary 
forms of Syphilis as indurated chancres, maculo-papu- 
lar eruptions, genital ulcerative lesions, pustular 
and pemphigoid lesions, are marvellous. All these , 
and the night pains of lues, soon disappear as if by 
magic. It has the same effects on tertiary and other 
forms of the disease while its effects on hereditary 
Syphilis are wonderful. Para -syphilitic lesions like 
tabes dorsalis, progressive paralysis, etc. are said 
not to be influenced by it; however, even in these 
diseases, it should be used in their early stages. 
In Syphilis complicated with other diseases as 
tuberculosis, its results are wonderful, while it 
also is of great value in severe pulmonary Syphilis. 
If necessary, the dose may be repeated at suitable 
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intervals which are said to be about four weeks. 
Wechselmann ( "On Re- injections with Dioxy -diamino- 
arseno- benzol ", Deutsche Med. Woch. No.37, September 
5th, 1910) indeed regards a re- injection as admirable 
and efficacious. According to him, it may be made 
after eight days,but it is more effectively given 
three to four weeks after the first injection. If an 
insufficient curative dose be, however, administered 
at first, the "Herxheimer Reaction" (already referred 
to elsewhere) sometimes appears. 
The arsenic is eliminated by way of the urine 
and faeces but at a slower rate than with Atoxyl, 
Arsacetin and Arseno- phenyl- glycin when injected sub- 
cutaneously. In the former two drugs mentioned here, 
the arsenic is excreted quickly and almost completely 
by the kidneys; while in the latter and in Salvarsan, 
it is largely found in the faeces. 
There is diversity of opinion as to the recur- 
rence of the disease after treatment by "606 ". Dr 
H. Isaac (Berlin Klin . Woch. No .33, August 15, 1910) 
in Lassar's Clinic at Berlin did not observe any re- 
currences. Others, however, have observed them but 
these cases are very rare and seem to have occurred 
mostly after the administration of insufficient doses. 
It is indicated in all cases of Syphilis except the 
following occur along with the disease:- 
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(1) Severe and non -syphilitic disease of the 
retina and optic nerve. 
(2) Severe heart and vascular disease. 
(3) Severe pulmonary affections. 
(4) Severe non -syphilitic kidney affections. 
(5) Advanced degenerative processes of the 
central nervous system. 
(6) Those suffering from Angina and fever. 
Its action on spirochaetae in corpore is marvel- 
lous, all disappearing from the blood in from 24 to 
48 hours after injection. 
The results on the Wassermann blood reaction vary 
and various observers record different percentages of 
the reaction becoming and remaining negative after 
an injection. Its clinical value as far as can be 
judged from clinical reports can be summarised as 
follows: - 
"Arseno- benzol is a specific in Syphilis, and 
exceeds all other anti -syphilitic remedies in its 
action. It stays all forms and stages of the dis- 
ease" . (Dr Sellei, Manch. Med. Wochens. No.39) . 
Under its action all patients increase in weight. 
Ehrlich says that in adequate doses it can sterilise 
the body, and in this direction it is interesting to 
note that pus removed at the site of injection where 
infiltration and inflammation have occurred, has al- 
ways been reported as sterile. 
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As far then as clinical tests go, it certainly 
- leaves in the shade Mercur r, the Iodides and all 
other substances hitherto discovered and used in the 
treatment of human Syphilis. 
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SUMMARY AND CONCLUSIONS. 
In this, the concluding portion of my work, I 
intend to briefly state in numerical sequence the 
chief points about the various arylarsonates and 
their relative advantage, together with some remarks 
as to whether they are likely to replace mercurial 
treatment. 
(1) The chief points about ATOXYL are its vary- 
ing composition, its liability to contamination dur- 
ing the process of manufacture, its relative toxicity 
and its liability to decomposition under various 
physical and chemical conditions. Besides, there 
is its injurious action on the neuro- retinal visual 
apparatus. There is a conflict of opinion regarding 
its value. Although it is able to modify primary, 
secondary and various tertiary specific lesions, it 
fails in hereditary and parasyphilitic conditions. 
The fact that it sometimes succeeds where Mercury and 
the Iodides have failed, is no reason why it should 
be adopted as a routine mode of treatment in human 
Syphilis in view of the better results obtained by 
some of the newer arsenical preparations. The only 
conditions where it is likely to replace Mercury are 
in the various cases - already mentioned -- where that 
drug is contra -indicated or cannot be tolerated. 
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(2) SOAMIN recommends itself to us on account of 
its definite chemical composition, its purity and re- 
lative non -toxicity. There is a unanimity of opinion 
as to its beneficial effects in primary, secondary 
and tertiary specific lesions. Authorities are also 
agreed as to its failure in hereditary and parasyphil- 
itic conditions. It certainly succeeds where Mercury 
and the Iodides sometimes fail or are contra-indicated. 
Very seldom does it give rise to toxic effects or to 
visual disturbances. In conditions where Mercury is 
contra -indicated or useless, it is likely to replace 
it, and again in the Tropics where on account of the 
debility caused by climatic and malarial conditions it 
cannot be given. It certainly causes an increase in 
weight in almost every case and acts as a tonic in 
tropical debility. Its advantage over Mercury is 
that it causes no salivation, stomatitis or spongy 
gums. Likewise, in moderate remedial doses, it does 
not cause diarrhoea, a point of great value, as com- 
pared with Mercury, in the tropics where diarrhoea is 
such a prevalent disease or sr_mptöm. 
(3) ARSACETIN recommends itself to us on account 
of its purity, marked stability and the rapid manner 
in which it modifies all forms of the disease except 
hereditary and parasyphilitic ones. Compared with 
Soamin and Atoxyl, the weight of clinical evidence is 
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in its favour. It does not cause neuro- retinal ocu- 
lar disturbances (like Atoxyl), is relatively non- 
toxic, well borne and certainly indicated where Mer- 
cury is useless or contra- indicated. When possible, 
it should be followed by a mercurial course, and is 
indicated in tropical conditions. Under its action, 
patients rapidly increase in weight and it acts in- 
directly as a tonic. 
Colonel Lambkin(1), in speaking of this drug and. 
Soamin, said that the good results he obtained in his 
cases strengthened his conviction that we had in them, 
a secondary specific for Syphilis, at least from a 
preventive and remedial point of view. As regards 
the former, he had then under his care cases with 
undoubted primary specific lesions which were treated 
with Soamin and which were closely observed every 
week for ten months without developing any further 
sign of the disease. From the remedial point of 
view the good results he obtained speak for it. But 
as a curative agent, it is beyond us all at present 
to give a positive answer to this all -important ques- 
tion; time and clinical experience alone would en- 
able us to do so. This could not be done until it 
was proved beyond doubt that arylarsonates were cap- 
able of permanently expelling the spirochaetae pallida 
from the system, as indicated by the patient being 
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rendored capable of re- infection. Neisser's success- 
ful experiments on apes from this point of view jus- 
tified us in hoping for this end. Until the question 
as to the capability of arylarsonates bringing about 
a permanent cure was fully established, he would give 
Mercury after a course of treatment by arylarsonates. 
Later on, the same author(2)in speaking of the ary- 
larsonates, said that our present knowledge of the 
power of these arsenical salts over Syphilis was in a 
very elementary stage, but he looked forward to fur- 
ther experience of them and improved technique lead- 
ing us to that goal in the treatment of Syphilis which 
had already been attained with dourine. Regarding 
Arsacetin, Neisser(3)says that he has hitherto applied 
the mercurial and arsacetin treatment simultaneously, 
but perhaps they could be carried out alternately. 
(4) ARSENO- PHENYL -GLYCIN has been fully dealt 
with elsewhere and it only remains for me to say that, 
despite the brilliant results which follow its admin- 
istration, there is no likelihood, on account of its 
instability and the inconvenient form in which it is 
supplied, of it ever replacing Mercury, and even other 
arylarsonates like Soamin, Arsacetin, Atoxylate of 
Mercury and Salvarsan in the treatment of human Syph- 
ilis. 
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In reviewing the arylarsonates hitherto discuss- 
ed and used before the introduction of Salvarsan and 
Mercury Atoxylate, Colonel Lambkin(4)said that it was 
far too soon to express an opinion as to whether they 
were likely to prove of permanent benefit in Syphilis 
or whether they were likely to replace Mercury in 
the disease, but the results were encouraging. 
Whether they had any abortive or prophylactic effect 
on the future development of the disease after inocu- 
lation, he was unable to speak except to note that 
when given at an early date they delayed and modified 
considerably the secondary signs of the disease and 
that they had very beneficial effects on all specific 
mucous ulcerations. It was well established, he 
thought, that in the arylarsonates we had a second 
specific for Syphilis, the importance of which could 
not well be exaggerated. 
(5) In MERCURY ATOXYLATE we have a very potent 
drug exerting both the specific actions of Atoxyl and 
Mercury on the spirochaetae, both in vitro and in 
corpore. It is far more potent than Calomel injec- 
tions alone. If applied to suitable cases and care 
taken in its administration, it is a safe drug. 
Lambkin and others who have used it, prefer it to 
1.0 roury over which it has a decided advantage in the 
rapidity with which it controls the symptoms of the 
disease. I am of opinion that this drug will cer- 
tainly displace the mercurial treatment of Syphilis. 
(6) SALVARSAN or Ehrlich Hata's "606" is the most 
potent drug hitherto discovered and applied to the 
treatment of human Syphilis in its protean aspects. 
Its stability, non -toxicity, ease of administration, 
rapidity of action, the fact that it does not affect 
the neuro -retinal visual apparatus, all speak in its 
favour. It is indicated in all forms of the disease 
viz. primary, secondary, tertiary and hereditary lues, 
while it has a marked effect in combating some of the 
ymptoms occurrinm_ in parasyphilis. It has yielded 
marvellous results in alleviating the various crises 
of locomotor ataxia of specific origin. With the 
doses at present used, cases have been said to recur, 
but Professor Herxheimer(5), Dr H. Isaac(6)and others 
have never seen them. Dr Leonor Michaelis(7)found 
that the recovery was absolute in a few days in most 
of his cases, while Dr Gourwitsch and S. Bormann(8) 
selected cases which had been treated with the most 
powerful of mercurial methods and found that the com- 
parison of these with Arseno- benzol proved the over- - 
whelming value of the latter. 
By way.of conclusion, I may say that from a per- 
sonal experience of the effects produced by Salvarsan 
and the reports of eminent authorities, that the drug 
jF 
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is absolutely superior in Syphilis to any other known 
drug, and. that a single injection, in a suitable case, 
will produce results obtained only after years of_ 
treatment with Mercury. This latter drug, however, 
is not to be discarded because it seems to have been 
proved that there are strains of spiroçhaetaç that 
are arsenic-proof. In the same way, there are strains 
that are Mercury -proof. Perhaps by using one drug 
after the other we may be able to destroy all these 
various strains and so bring about a permanent cure 
of the disease. 
In spite of the pre -eminence of Salvarsan as the 
best curative and prophylactic agent hitherto dis- 
covered for Syphilis, I venture to state that the 
last word has not yet been spoken on the treatment of. 
Syphilis. 
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